Expression	O
of	O
tal-1	B-protein
and	O
GATA-binding	B-protein
proteins	I-protein
during	O
human	O
hematopoiesis	O
.	O

Tal-1	B-protein
rearrangements	O
are	O
associated	O
with	O
nearly	O
30	O
%	O
of	O
human	O
T	O
acute	O
lymphoblastic	O
leukemia	O
.	O

Tal-1	B-DNA
gene	I-DNA
encodes	O
a	O
putative	O
transcription	B-protein
factor	I-protein
with	O
a	O
basic	B-protein
helix-loop-helix	I-protein
domain	I-protein
and	O
is	O
known	O
to	O
be	O
predominantly	O
expressed	O
in	O
hematopoietic	B-cell_type
cells	I-cell_type
.	O

We	O
investigated	O
the	O
pattern	O
of	O
tal-1	B-protein
expression	O
in	O
purified	B-cell_type
human	I-cell_type
hematopoietic	I-cell_type
cells	I-cell_type
by	O
in	O
situ	O
hybridization	O
and	O
reverse	B-protein
transcriptase	I-protein
polymerase	I-protein
chain	O
reaction	O
analysis	O
.	O

Both	O
methods	O
demonstrated	O
that	O
the	O
tal-1	B-protein
gene	O
is	O
expressed	O
in	O
megakaryocytes	O
and	O
erythroblasts	O
as	O
well	O
as	O
in	O
basophilic	B-cell_type
granulocytes	I-cell_type
.	O

In	O
addition	O
,	O
our	O
results	O
indicate	O
that	O
the	O
tal-1	B-DNA
1A	I-DNA
promoter	I-DNA
,	O
which	O
contains	O
two	O
consensus	O
GATA-binding	B-DNA
sites	I-DNA
,	O
is	O
active	O
mainly	O
in	O
these	O
lineages	O
.	O

Because	O
the	O
GATA-1	B-DNA
gene	I-DNA
is	O
known	O
to	O
transactivate	O
several	O
genes	O
specific	O
for	O
the	O
erythroid	B-cell_type
,	I-cell_type
megakaryocytic	I-cell_type
,	I-cell_type
and	I-cell_type
mastocytic/basophilic	I-cell_type
lineages	I-cell_type
,	O
we	O
studied	O
GATA-1	B-protein
expression	O
in	O
these	O
purified	O
hematopoietic	B-cell_type
cells	I-cell_type
.	O

We	O
found	O
that	O
GATA-1	B-DNA
and	I-DNA
tal-1	I-DNA
genes	I-DNA
are	O
coexpressed	O
in	O
these	O
three	O
lineages	O
.	O

Remarkably	O
,	O
the	O
expression	O
of	O
both	O
genes	O
is	O
downmodulated	O
during	O
erythroid	O
and	O
megakaryocytic	O
terminal	O
maturation	O
.	O

In	O
immature	B-cell_type
hematopoietic	I-cell_type
cells	I-cell_type
,	O
tal-1	B-DNA
and	I-DNA
GATA-1	I-DNA
genes	I-DNA
are	O
coexpressed	O
in	O
committed	B-cell_type
progenitors	I-cell_type
cells	I-cell_type
(	O
CD34+/CD38	B-cell_line
(	I-cell_line
2+	I-cell_line
)	I-cell_line
)	O
,	O
whereas	O
they	O
are	O
not	O
detectable	O
in	O
the	O
most	O
primitive	B-cell_type
cells	I-cell_type
(	O
CD34	B-cell_line
(	I-cell_line
2+	I-cell_line
)	I-cell_line
/CD38-	I-cell_line
)	O
.	O

In	O
contrast	O
,	O
GATA-2	B-protein
is	O
strongly	O
expressed	O
in	O
both	O
most	B-cell_type
primitive	I-cell_type
and	I-cell_type
committed	I-cell_type
progenitors	I-cell_type
cells	I-cell_type
,	O
whereas	O
GATA-3	B-protein
is	O
mostly	O
detected	O
in	O
most	O
primitive	O
ones	O
.	O

Altogether	O
our	O
results	O
strongly	O
suggest	O
that	O
GATA-1	B-protein
modulates	O
the	O
transcription	O
of	O
tal-1	B-protein
during	O
the	O
differentiation	O
of	O
the	O
erythroid	B-cell_type
,	I-cell_type
megakaryocytic	I-cell_type
,	I-cell_type
and	I-cell_type
basosophilic	I-cell_type
lineages	I-cell_type
.	O

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Expression	NULL
of	NULL
tal-1	NULL
and	NULL
GATA-Binding	NULL
Proteins	NULL
During	NULL
Human	NULL
Hematopoiesis	NULL
By	NULL
Marc-Andre	NULL
Mouthon	NULL
,	NULL
Olivier	NULL
Bernard	NULL
,	NULL
Maria-Teresa	NULL
Mitjavila	NULL
,	NULL
Paul-Henri	NULL
Romeo	NULL
,	NULL
William	NULL
Vainchenker	NULL
,	NULL
and	NULL
Daniele	NULL
Mathieu-Mahul	NULL
Tal-1	NULL
rearrangements	NULL
are	NULL
associated	NULL
with	NULL
nearly	NULL
30	NULL
%	NULL
of	NULL
human	NULL
T	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Ta/-1	NULL
gene	NULL
encodes	NULL
a	NULL
putative	NULL
transcription	NULL
factor	NULL
with	NULL
a	NULL
basic	NULL
helix-loop-helix	NULL
domain	NULL
and	NULL
is	NULL
known	NULL
to	NULL
be	NULL
predominantly	NULL
expressed	NULL
in	NULL
hematopoietic	NULL
cells	NULL
We	NULL
investigated	NULL
the	NULL
pattern	NULL
of	NULL
ta/-1	NULL
expression	NULL
in	NULL
purified	NULL
human	NULL
hematopoietic	NULL
cells	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
reverse	NULL
transcriptase	NULL
polymerase	NULL
chain	NULL
reaction	NULL
analysis	NULL
.	NULL

Both	NULL
methods	NULL
demonstrated	NULL
that	NULL
the	NULL
ta/-1	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
megakaryocytes	NULL
and	NULL
erythroblasts	NULL
as	NULL
well	NULL
as	NULL
in	NULL
basophilic	NULL
granulocytes	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
tal-1	NULL
1A	NULL
promoter	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
consensus	NULL
GATA-binding	NULL
sites	NULL
,	NULL
is	NULL
active	NULL
mainly	NULL
in	NULL
these	NULL
lineages	NULL
.	NULL

Because	NULL
the	NULL
GATA-1	NULL
gene	NULL
is	NULL
known	NULL
to	NULL
transactivate	NULL
several	NULL
genes	NULL
specific	NULL
for	NULL
the	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mastocytic/basophilic	NULL
lineages	NULL
,	NULL
we	NULL
studied	NULL
HE	NULL
ftal-1	NULL
gene	NULL
,	NULL
also	NULL
called	NULL
SCL	NULL
or	NULL
TCLS5	NULL
,	NULL
was	NULL
originally	NULL
identified	NULL
because	NULL
of	NULL
its	NULL
disruption	NULL
by	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
p32	NULL
;	NULL
q11	NULL
)	NULL
translocation	NULL
observed	NULL
in	NULL
an	NULL
immature	NULL
T-cell	NULL
line	NULL
(	NULL
DU	NULL
528	NULL
)	NULL
and	NULL
in	NULL
the	NULL
leukemic	NULL
cells	NULL
of	NULL
patients	NULL
with	NULL
acute	NULL
T-cell	NULL
leukemia	NULL
(	NULL
T-ALL	NULL
)	NULL
.	NULL

``	NULL
*	NULL
In	NULL
addition	NULL
to	NULL
the	NULL
3	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
T-ALL	NULL
who	NULL
display	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
,	NULL
``	NULL
an	NULL
additional	NULL
12	NULL
%	NULL
to	NULL
25	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
T-ALL	NULL
without	NULL
evident	NULL
1p32	NULL
chromosomal	NULL
abnormality	NULL
exhibit	NULL
two	NULL
site-specific	NULL
V	NULL
(	NULL
D	NULL
)	NULL
J	NULL
recombinase-mediated	NULL
deletions	NULL
,	NULL
fa/	NULL
``	NULL
``	NULL
and	NULL
tal	NULL
``	NULL
,	NULL
which	NULL
affect	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
tal-1	NULL
gene	NULL
.	NULL
``	NULL

These	NULL
tal	NULL
``	NULL
recombinations	NULL
occur	NULL
between	NULL
the	NULL
5	NULL
noncoding	NULL
sequences	NULL
of	NULL
tal-1	NULL
and	NULL
another	NULL
locus	NULL
centromeric	NULL
to	NULL
ta/-1	NULL
(	NULL
SIL	NULL
)	NULL
and	NULL
lead	NULL
to	NULL
an	NULL
interstitial	NULL
deletion	NULL
of	NULL
about	NULL
100	NULL
kb	NULL
on	NULL
chromosome	NULL
1	NULL
.	NULL

The	NULL
SIL	NULL
gene	NULL
is	NULL
transcribed	NULL
in	NULL
most	NULL
of	NULL
the	NULL
hematopoietic	NULL
lineages	NULL
and	NULL
notably	NULL
in	NULL
T	NULL
cells	NULL
.	NULL
'	NULL

''	NULL
Recently	NULL
,	NULL
the	NULL
tal-1	NULL
gene	NULL
was	NULL
found	NULL
to	NULL
be	NULL
juxtaposed	NULL
with	NULL
the	NULL
T-cell	NULL
receptor	NULL
3	NULL
chain	NULL
gene	NULL
(	NULL
TCR-8	NULL
)	NULL
in	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
7	NULL
)	NULL
(	NULL
p32	NULL
;	NULL
q35	NULL
)	NULL
translocation	NULL
observed	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
T-ALL	NULL
.	NULL
``	NULL

In	NULL
both	NULL
types	NULL
of	NULL
fal-1	NULL
alterations	NULL
(	NULL
re-ciprocal	NULL
translocations	NULL
or	NULL
interstitial	NULL
deletions	NULL
)	NULL
,	NULL
the	NULL
coding	NULL
sequences	NULL
of	NULL
ra/-1	NULL
are	NULL
placed	NULL
under	NULL
the	NULL
influence	NULL
of	NULL
genes	NULL
that	NULL
are	NULL
normally	NULL
expressed	NULL
in	NULL
the	NULL
T-cell	NULL
lineage	NULL
:	NULL
the	NULL
TCR-6	NULL
gene	NULL
in	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocations	NULL
,	NULL
the	NULL
TCR-8	NULL
gene	NULL
in	NULL
t	NULL
(	NULL
1	NULL
;	NULL
7	NULL
)	NULL
translocations	NULL
,	NULL
or	NULL
the	NULL
SIL	NULL
gene	NULL
in	NULL
the	NULL
case	NULL
of	NULL
taÂ®	NULL
rearrangements	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
physiologic	NULL
consequence	NULL
of	NULL
these	NULL
specific	NULL
chromosomal	NULL
rearrangements	NULL
is	NULL
the	NULL
transcriptional	NULL
deregulation	NULL
of	NULL
tal-1	NULL
coding	NULL
sequences	NULL
in	NULL
a	NULL
T-cell	NULL
clone	NULL
.	NULL

**	NULL
``	NULL
``	NULL
~	NULL
``	NULL
>	NULL
Two	NULL
lines	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
the	NULL
tal-1	NULL
gene	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
T-cell	NULL
tumorigenesis	NULL
.	NULL

First	NULL
,	NULL
recurrent	NULL
breakage	NULL
of	NULL
ra/-1	NULL
is	NULL
often	NULL
associated	NULL
with	NULL
T-ALL	NULL
and	NULL
occurs	NULL
exclusively	NULL
in	NULL
this	NULL
type	NULL
of	NULL
tumor	NULL
;	NULL
second	NULL
,	NULL
ta/-1	NULL
gene	NULL
expression	NULL
is	NULL
found	NULL
in	NULL
several	NULL
T-cell	NULL
lines	NULL
and	NULL
in	NULL
leukemic	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
T-ALL	NULL
,	NULL
without	NULL
evident	NULL
fa/-1	NULL
gene	NULL
alteration	NULL
.	NULL

'*'*	NULL
Taken	NULL
together	NULL
,	NULL
these	NULL
observations	NULL
are	NULL
more	NULL
than	NULL
coincidental	NULL
and	NULL
strongly	NULL
suggest	NULL
that	NULL
an	NULL
inappropriate	NULL
level	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
product	NULL
is	NULL
a	NULL
critical	NULL
event	NULL
in	NULL
T-cell	NULL
leukemogenesis	NULL
.	NULL

The	NULL
most	NULL
remarkable	NULL
feature	NULL
of	NULL
the	NULL
putative	NULL
ta/-1	NULL
gene	NULL
product	NULL
is	NULL
that	NULL
it	NULL
possesses	NULL
a	NULL
domain	NULL
able	NULL
to	NULL
form	NULL
two	NULL
am-phiphatic	NULL
a	NULL
helices	NULL
separated	NULL
by	NULL
an	NULL
intervening	NULL
loop	NULL
and	NULL
preceded	NULL
by	NULL
a	NULL
cluster	NULL
of	NULL
basic	NULL
residues	NULL
that	NULL
define	NULL
the	NULL
bHLH	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

***	NULL
``	NULL
``	NULL
Several	NULL
members	NULL
of	NULL
this	NULL
family	NULL
are	NULL
known	NULL
to	NULL
be	NULL
implicated	NULL
in	NULL
mammalian	NULL
cell	NULL
growth	NULL
Blood	NULL
,	NULL
Vol	NULL
81	NULL
,	NULL
No	NULL
3	NULL
(	NULL
February	NULL
1	NULL
)	NULL
,	NULL
1993	NULL
:	NULL
pp	NULL
647-655	NULL
GATA-1	NULL
expression	NULL
in	NULL
these	NULL
purified	NULL
hematopoietic	NULL
cells	NULL
.	NULL

We	NULL
found	NULL
that	NULL
GATA-1	NULL
and	NULL
ta/-1	NULL
genes	NULL
are	NULL
coexpressed	NULL
in	NULL
these	NULL
three	NULL
lineages	NULL
.	NULL

Remarkably	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
both	NULL
genes	NULL
is	NULL
downmodulated	NULL
during	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
terminal	NULL
maturation	NULL
.	NULL

In	NULL
immature	NULL
hematopoietic	NULL
cells	NULL
,	NULL
tal-1	NULL
and	NULL
GATA-1	NULL
genes	NULL
are	NULL
coexpressed	NULL
in	NULL
committed	NULL
progenitors	NULL
cells	NULL
(	NULL
CD34*/CD38*+*	NULL
)	NULL
,	NULL
whereas	NULL
they	NULL
are	NULL
not	NULL
detectable	NULL
in	NULL
the	NULL
most	NULL
primitive	NULL
cells	NULL
(	NULL
CD34**/CD38-	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GATA-2	NULL
is	NULL
strongly	NULL
expressed	NULL
in	NULL
both	NULL
most	NULL
primitive	NULL
and	NULL
committed	NULL
progenitors	NULL
cells	NULL
,	NULL
whereas	NULL
GATA-3	NULL
is	NULL
mostly	NULL
detected	NULL
in	NULL
most	NULL
primitive	NULL
ones	NULL
.	NULL

Altogether	NULL
our	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
GATA-1	NULL
modulates	NULL
the	NULL
transcription	NULL
of	NULL
ta/-1	NULL
during	NULL
the	NULL
differentiation	NULL
of	NULL
the	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
basosophilic	NULL
lineages	NULL
.	NULL

Â©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

regulation	NULL
and	NULL
differentiation	NULL
,	NULL
such	NULL
as	NULL
Myc	NULL
,	NULL
MyoD	NULL
,	NULL
``	NULL
Â®	NULL
and	NULL
the	NULL
immunoglobulin	NULL
enhancer-binding	NULL
proteins	NULL
E12	NULL
and	NULL
E47	NULL
.	NULL

The	NULL
bHLH	NULL
motif	NULL
of	NULL
these	NULL
proteins	NULL
is	NULL
directly	NULL
responsible	NULL
for	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
with	NULL
other	NULL
HLH	NULL
proteins	NULL
involved	NULL
in	NULL
transcription	NULL
regulation	NULL
.	NULL
'	NULL

''	NULL
``	NULL
*	NULL
Ta/-1	NULL
protein	NULL
is	NULL
able	NULL
in	NULL
vitro	NULL
,	NULL
in	NULL
association	NULL
with	NULL
the	NULL
E47/E12	NULL
bHLH	NULL
proteins	NULL
,	NULL
to	NULL
bind	NULL
the	NULL
E	NULL
box	NULL
motif	NULL
found	NULL
in	NULL
several	NULL
eukaryotic	NULL
transcriptional	NULL
enhancers	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
ia/-1	NULL
heterodimers	NULL
may	NULL
also	NULL
function	NULL
in	NULL
vivo	NULL
as	NULL
transcriptional	NULL
regulatory	NULL
factors	NULL
that	NULL
influence	NULL
cell	NULL
type	NULL
determination	NULL
during	NULL
hematopoiesis	NULL
.	NULL
``	NULL

In	NULL
previous	NULL
studies	NULL
,	NULL
the	NULL
ta/-1	NULL
gene	NULL
was	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
only	NULL
in	NULL
early	NULL
myeloid	NULL
and	NULL
erythroid	NULL
leukemic	NULL
cell	NULL
lines	NULL
,	NULL
whereas	NULL
no	NULL
expression	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
thymus	NULL
or	NULL
in	NULL
normal	NULL
peripheral	NULL
T-lymphocytes	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
the	NULL
ta/-1	NULL
gene	NULL
was	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
several	NULL
megakaryocytic	NULL
cell	NULL
lines	NULL
``	NULL
``	NULL
and	NULL
murine	NULL
mast	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
A	NULL
recent	NULL
study	NULL
``	NULL
using	NULL
an	NULL
antisense	NULL
strategy	NULL
in	NULL
the	NULL
erythroleu-kemia	NULL
cell	NULL
line	NULL
K562	NULL
suggests	NULL
that	NULL
fa/-1	NULL
is	NULL
involved	NULL
in	NULL
self-renewal	NULL
of	NULL
K562	NULL
cells	NULL
and	NULL
gives	NULL
rise	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
tal-1	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
proliferation	NULL
of	NULL
normal	NULL
erythroid	NULL
cells	NULL
.	NULL

Because	NULL
most	NULL
of	NULL
these	NULL
studies	NULL
have	NULL
been	NULL
performed	NULL
on	NULL
leukemic	NULL
cell	NULL
lines	NULL
,	NULL
we	NULL
wanted	NULL
to	NULL
investigate	NULL
the	NULL
pattern	NULL
of	NULL
tal-1	NULL
expression	NULL
in	NULL
normal	NULL
hematopoiesis	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
we	NULL
defined	NULL
the	NULL
bone	NULL
marrow	NULL
hematopoietic	NULL
lineages	NULL
that	NULL
express	NULL
the	NULL
ta/-1	NULL
gene	NULL
.	NULL

Our	NULL
data	NULL
clearly	NULL
indicate	NULL
that	NULL
the	NULL
From	NULL
INSERM	NULL
91	NULL
,	NULL
Hopital	NULL
Henri	NULL
Mondor	NULL
,	NULL
CrÃ©teil	NULL
,	NULL
France	NULL
;	NULL
INSERM	NULL
U	NULL
301	NULL
,	NULL
Institut	NULL
de	NULL
GÃ©nÃ©tique	NULL
MolÃ©culaire	NULL
,	NULL
Paris	NULL
,	NULL
France	NULL
;	NULL
and	NULL
INSERM	NULL
U	NULL
362	NULL
,	NULL
Institut	NULL
Gustave	NULL
Roussy	NULL
,	NULL
Villejuif	NULL
,	NULL
France	NULL
.	NULL

Submitted	NULL
April	NULL
30	NULL
,	NULL
1992	NULL
;	NULL
accepted	NULL
October	NULL
2	NULL
,	NULL
1992	NULL
.	NULL

Supported	NULL
by	NULL
Fondation	NULL
contre	NULL
la	NULL
LeucÃ©mie	NULL
and	NULL
Association	NULL
contre	NULL
le	NULL
Cancer	NULL
(	NULL
ARC	NULL
)	NULL
.	NULL

M.-A.M.	NULL
and	NULL
O.B	NULL
.	NULL

were	NULL
supported	NULL
by	NULL
a	NULL
fellowship	NULL
from	NULL
Ligue	NULL
Nationale	NULL
Contre	NULL
le	NULL
Cancer	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Marc-Andre	NULL
Mouthon	NULL
,	NULL
INSERM	NULL
U362	NULL
,	NULL
Institut	NULL
Gustave	NULL
Roussy	NULL
,	NULL
39	NULL
rue	NULL
Camille	NULL
Desmoulin	NULL
,	NULL
94805	NULL
Villejuif	NULL
,	NULL
France	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

Â©	NULL
1993	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
647	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

648	NULL
tal-1	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
megakaryocytes	NULL
,	NULL
erythroblasts	NULL
,	NULL
and	NULL
basophilic	NULL
granulocytes	NULL
and	NULL
in	NULL
their	NULL
progenitor	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
this	NULL
pattern	NULL
of	NULL
expression	NULL
parallels	NULL
that	NULL
of	NULL
GATA-1	NULL
,	NULL
which	NULL
is	NULL
restricted	NULL
to	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mastocytic/basophilic	NULL
lineages	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
In	NULL
addition	NULL
,	NULL
fa/-1	NULL
and	NULL
GATA-1	NULL
gene	NULL
expression	NULL
is	NULL
simultaneously	NULL
downmodulated	NULL
during	NULL
terminal	NULL
differentiation	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Isolation	NULL
of	NULL
Hematopoietic	NULL
Cells	NULL
Bone	NULL
marrow	NULL
and	NULL
blood	NULL
cells	NULL
.	NULL

-	NULL
Bone	NULL
marrow	NULL
aspirates	NULL
were	NULL
obtained	NULL
from	NULL
normal	NULL
adult	NULL
donors	NULL
after	NULL
informed	NULL
consent	NULL
in	NULL
accordance	NULL
with	NULL
the	NULL
institutional	NULL
guidelines	NULL
of	NULL
the	NULL
Committee	NULL
on	NULL
Human	NULL
In-vestigation	NULL
.	NULL

Cells	NULL
were	NULL
separated	NULL
to	NULL
obtain	NULL
both	NULL
low-density	NULL
cells	NULL
and	NULL
granulocytic	NULL
precursors	NULL
.	NULL

First	NULL
,	NULL
total	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
depleted	NULL
of	NULL
erythrocytes	NULL
by	NULL
sedimentation	NULL
at	NULL
1g	NULL
over	NULL
a	NULL
Ficoll-metrizoate	NULL
gradient	NULL
(	NULL
d	NULL
=	NULL
1.077	NULL
g/mL	NULL
)	NULL
(	NULL
Seromed	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Second	NULL
,	NULL
free	NULL
erythrocyte	NULL
cells	NULL
were	NULL
separated	NULL
by	NULL
velocity	NULL
centrifugation	NULL
at	NULL
400g	NULL
over	NULL
a	NULL
Ficoll-metrizoate	NULL
gradient	NULL
(	NULL
d	NULL
=	NULL
1.077	NULL
g/mL	NULL
)	NULL
.	NULL

Low-density	NULL
cells	NULL
were	NULL
recovered	NULL
at	NULL
the	NULL
interphase	NULL
of	NULL
the	NULL
gradient	NULL
,	NULL
whereas	NULL
polymorphs	NULL
,	NULL
metamyelocytes	NULL
,	NULL
and	NULL
myelocytes	NULL
were	NULL
obtained	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
the	NULL
tube	NULL
and	NULL
represented	NULL
more	NULL
than	NULL
90	NULL
%	NULL
of	NULL
the	NULL
nucleated	NULL
cells	NULL
present	NULL
in	NULL
this	NULL
cell	NULL
fraction	NULL
.	NULL

CD34*	NULL
cells	NULL
were	NULL
recovered	NULL
from	NULL
the	NULL
marrow	NULL
low-density	NULL
cells	NULL
by	NULL
the	NULL
immunomagnetic	NULL
bead	NULL
technique	NULL
using	NULL
the	NULL
anti-CD34	NULL
mono-clonal	NULL
antibody	NULL
QBENDIO	NULL
(	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
Dr	NULL
M.	NULL
Greaves	NULL
,	NULL
London	NULL
,	NULL
UK	NULL
)	NULL
;	NULL
the	NULL
target	NULL
cell	NULL
to	NULL
bead	NULL
ratio	NULL
was	NULL
1:5	NULL
(	NULL
Dynabeads	NULL
M-450	NULL
;	NULL
Dynal	NULL
,	NULL
Oslo	NULL
,	NULL
Norway	NULL
)	NULL
.	NULL

CD34*	NULL
cells	NULL
were	NULL
isolated	NULL
using	NULL
a	NULL
magnetic	NULL
particle	NULL
concentrator	NULL
and	NULL
detached	NULL
by	NULL
a	NULL
chymopapain	NULL
treatment	NULL
(	NULL
130	NULL
U/mL	NULL
for	NULL
2	NULL
minutes	NULL
,	NULL
repeated	NULL
two	NULL
times	NULL
)	NULL
.	NULL
``	NULL

The	NULL
CD34*	NULL
cell	NULL
recovery	NULL
was	NULL
about	NULL
1	NULL
%	NULL
of	NULL
the	NULL
low-density	NULL
bone	NULL
marrow	NULL
cells	NULL
.	NULL

After	NULL
May-Griinwald	NULL
Giemsa	NULL
staining	NULL
,	NULL
the	NULL
majority	NULL
(	NULL
85	NULL
%	NULL
to	NULL
95	NULL
%	NULL
)	NULL
of	NULL
these	NULL
cells	NULL
had	NULL
the	NULL
morphology	NULL
of	NULL
blast	NULL
cells	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
this	NULL
cell	NULL
fraction	NULL
was	NULL
further	NULL
assessed	NULL
by	NULL
immunofluorescence	NULL
labeling	NULL
with	NULL
another	NULL
anti-CD34	NULL
antibody	NULL
(	NULL
My10	NULL
,	NULL
a	NULL
generous	NULL
gift	NULL
from	NULL
C.	NULL
Civin	NULL
,	NULL
Baltimore	NULL
,	NULL
MD	NULL
)	NULL
after	NULL
an	NULL
overnight	NULL
culture	NULL
,	NULL
and	NULL
it	NULL
was	NULL
estimated	NULL
to	NULL
be	NULL
over	NULL
90	NULL
%	NULL
.	NULL

In	NULL
two	NULL
other	NULL
experiments	NULL
,	NULL
blood	NULL
cells	NULL
collected	NULL
for	NULL
autotransplantation	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
myeloma	NULL
after	NULL
chemotherapy	NULL
were	NULL
used	NULL
to	NULL
further	NULL
separate	NULL
CD34*	NULL
cells	NULL
into	NULL
two	NULL
fractions	NULL
CD38*	NULL
and	NULL
CD38~	NULL
.	NULL

Briefly	NULL
,	NULL
CD34*	NULL
cells	NULL
were	NULL
first	NULL
purified	NULL
by	NULL
the	NULL
immunomagnetic	NULL
bead	NULL
technique	NULL
as	NULL
above	NULL
,	NULL
and	NULL
after	NULL
an	NULL
overnight	NULL
incubation	NULL
,	NULL
CD34*	NULL
cells	NULL
were	NULL
labeled	NULL
with	NULL
an	NULL
anti-CD34	NULL
(	NULL
HPCA-2	NULL
)	NULL
and	NULL
an	NULL
anti-CD38	NULL
(	NULL
Leu-17	NULL
)	NULL
.	NULL

Both	NULL
antibodies	NULL
directly	NULL
coupled	NULL
to	NULL
fluorescein	NULL
isochiocyanate	NULL
(	NULL
FITC	NULL
)	NULL
and	NULL
phycoerythrin	NULL
(	NULL
PE	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
were	NULL
purchased	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
San	NULL
Jose	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
sorted	NULL
by	NULL
flow	NULL
cytometry	NULL
using	NULL
an	NULL
ATC	NULL
3000	NULL
fluocytometer	NULL
(	NULL
Odam-Bruker	NULL
,	NULL
Wissenburg	NULL
,	NULL
France	NULL
)	NULL
equipped	NULL
with	NULL
a	NULL
pair	NULL
of	NULL
70-um	NULL
nozzles	NULL
and	NULL
an	NULL
argon-ion	NULL
laser	NULL
(	NULL
Innova	NULL
,	NULL
70-4	NULL
;	NULL
Coherent	NULL
,	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
tuned	NULL
at	NULL
488	NULL
nm	NULL
.	NULL

Two	NULL
populations	NULL
of	NULL
CD34*	NULL
cells	NULL
were	NULL
sorted	NULL
as	NULL
described	NULL
``	NULL
``	NULL
and	NULL
according	NULL
to	NULL
the	NULL
criteria	NULL
of	NULL
cell	NULL
sorting	NULL
used	NULL
by	NULL
Coulombel	NULL
et	NULL
al	NULL
(	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

The	NULL
first	NULL
population	NULL
was	NULL
highly	NULL
fluorescent	NULL
for	NULL
CD34	NULL
and	NULL
negative	NULL
for	NULL
CD38	NULL
,	NULL
and	NULL
the	NULL
second	NULL
one	NULL
was	NULL
highly	NULL
fluorescent	NULL
for	NULL
CD38	NULL
and	NULL
positive	NULL
for	NULL
CD34	NULL
.	NULL

The	NULL
first	NULL
population	NULL
is	NULL
greatly	NULL
enriched	NULL
in	NULL
primitive	NULL
progenitor	NULL
cells	NULL
and	NULL
depleted	NULL
in	NULL
commited	NULL
pro-genitors	NULL
,	NULL
whereas	NULL
the	NULL
second	NULL
contains	NULL
commited-progenitors	NULL
(	NULL
BFU-E	NULL
,	NULL
CFU-E	NULL
,	NULL
CFU-GM	NULL
,	NULL
CFU-MK	NULL
)	NULL
(	NULL
Coulombel	NULL
et	NULL
al	NULL
manuscript	NULL
in	NULL
preparation	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
CD34~	NULL
cells	NULL
(	NULL
a	NULL
majority	NULL
of	NULL
T	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
and	NULL
a	NULL
minority	NULL
of	NULL
myeloid	NULL
and	NULL
erythroid	NULL
cells	NULL
)	NULL
obtained	NULL
from	NULL
the	NULL
previous	NULL
immunomagnetic	NULL
bead	NULL
separation	NULL
were	NULL
studied	NULL
.	NULL

Platelets	NULL
as	NULL
well	NULL
as	NULL
blood	NULL
samples	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
Centre	NULL
de	NULL
transfusion	NULL
du	NULL
Val	NULL
de	NULL
Marne	NULL
(	NULL
CrÃ©teil	NULL
,	NULL
France	NULL
)	NULL
.	NULL

Peripheral	NULL
blood	NULL
lymphocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
granulocytes	NULL
were	NULL
recovered	NULL
after	NULL
Fi-	NULL
MOUTHON	NULL
ET	NULL
AL	NULL
coll-metrizoate	NULL
gradient	NULL
.	NULL

Blood	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
a	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
was	NULL
used	NULL
as	NULL
a	NULL
source	NULL
for	NULL
basophilic	NULL
granulocytes	NULL
.	NULL

Thymic	NULL
cells	NULL
.	NULL

-	NULL
Human	NULL
thymus	NULL
were	NULL
obtained	NULL
from	NULL
children	NULL
following	NULL
thymectomy	NULL
and	NULL
separated	NULL
over	NULL
a	NULL
Ficoll-metrizoate	NULL
gradient	NULL
.	NULL

Leukemic	NULL
samples	NULL
.	NULL

-	NULL
Leukemic	NULL
patient	NULL
samples	NULL
were	NULL
provided	NULL
by	NULL
the	NULL
Hematology	NULL
Department	NULL
of	NULL
Hopital	NULL
Saint-Louis	NULL
(	NULL
Paris	NULL
,	NULL
France	NULL
)	NULL
.	NULL

They	NULL
include	NULL
a	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
(	NULL
HAH	NULL
)	NULL
,	NULL
an	NULL
acute	NULL
megakaryoblastic	NULL
leukemia	NULL
(	NULL
GEHE	NULL
)	NULL
,	NULL
T-cell	NULL
acute	NULL
leukemias	NULL
(	NULL
109	NULL
,	NULL
FOR	NULL
,	NULL
BUF	NULL
,	NULL
LAR	NULL
)	NULL
devoid	NULL
of	NULL
1p32	NULL
chromosomal	NULL
rearrangement	NULL
,	NULL
and	NULL
an	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
(	NULL
AML	NULL
)	NULL
type	NULL
4	NULL
according	NULL
to	NULL
the	NULL
French-American-British	NULL
(	NULL
FAB	NULL
)	NULL
classification	NULL
(	NULL
GAU	NULL
)	NULL
.	NULL

Cell	NULL
lines	NULL
.	NULL

-	NULL
Several	NULL
human	NULL
cell	NULL
lines	NULL
were	NULL
studied	NULL
.	NULL

They	NULL
included	NULL
HL	NULL
60	NULL
(	NULL
``	NULL
promyelocytic	NULL
'	NULL
)	NULL
,	NULL
K	NULL
562	NULL
(	NULL
erythroid	NULL
)	NULL
,	NULL
UT-7	NULL
(	NULL
pluripotent	NULL
with	NULL
predominant	NULL
erythroid	NULL
and	NULL
MK	NULL
markers	NULL
)	NULL
,	NULL
HEL	NULL
,	NULL
Dami	NULL
,	NULL
Meg-01	NULL
,	NULL
CMK	NULL
(	NULL
cell	NULL
lines	NULL
with	NULL
both	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
markers	NULL
)	NULL
,	NULL
MOLT-4	NULL
,	NULL
Jurkat	NULL
,	NULL
REX	NULL
,	NULL
SKW3	NULL
(	NULL
T-cell	NULL
lines	NULL
)	NULL
,	NULL
Nalm-6	NULL
(	NULL
pre-B-cell	NULL
line	NULL
)	NULL
,	NULL
and	NULL
Raji	NULL
(	NULL
Burkit	NULL
lymphoma	NULL
cell	NULL
line	NULL
)	NULL
.	NULL

They	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
or	NULL
Iscove	NULL
's	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
)	NULL
.	NULL

The	NULL
human	NULL
factor-dependent	NULL
cell	NULL
line	NULL
UT-7	NULL
was	NULL
grown	NULL
in	NULL
Iscove	NULL
's	NULL
medium	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
rhIL-3	NULL
(	NULL
100	NULL
U/mL	NULL
)	NULL
.	NULL

Cultures	NULL
Semisolid	NULL
culture	NULL
of	NULL
marrow	NULL
cells	NULL
.	NULL

-	NULL
CD34*	NULL
cells	NULL
were	NULL
cultured	NULL
by	NULL
the	NULL
methylcellulose	NULL
technique	NULL
to	NULL
obtain	NULL
BFU-E-derived	NULL
colonies	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Stimulating	NULL
factors	NULL
were	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
a	NULL
combination	NULL
of	NULL
recombinant	NULL
human	NULL
growth	NULL
factors	NULL
:	NULL
1	NULL
U/mL	NULL
erythropoietin	NULL
(	NULL
rhEpo	NULL
)	NULL
(	NULL
Amersham	NULL
,	NULL
Les	NULL
Ulis	NULL
,	NULL
France	NULL
)	NULL
,	NULL
50	NULL
ng/mL	NULL
stem	NULL
cell	NULL
factor	NULL
(	NULL
rhSCF	NULL
)	NULL
(	NULL
Amgen	NULL
,	NULL
Thousand	NULL
Oaks	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
100	NULL
U/mL	NULL
rhIL-3	NULL
(	NULL
Immunex	NULL
,	NULL
Seattle	NULL
,	NULL
Washington	NULL
,	NULL
DC	NULL
)	NULL
.	NULL

Cultures	NULL
were	NULL
incubated	NULL
in	NULL
a	NULL
fully	NULL
humidified	NULL
atmosphere	NULL
of	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
air	NULL
.	NULL

After	NULL
8	NULL
and	NULL
12	NULL
days	NULL
of	NULL
culture	NULL
,	NULL
BFU-E-derived	NULL
colonies	NULL
were	NULL
pipetted	NULL
off	NULL
under	NULL
an	NULL
inverted	NULL
microscope	NULL
and	NULL
pooled	NULL
in	NULL
order	NULL
to	NULL
obtain	NULL
a	NULL
pure	NULL
population	NULL
of	NULL
erythroblasts	NULL
for	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
RNA	NULL
extraction	NULL
.	NULL

Normal	NULL
megakaryocyte	NULL
culture	NULL
.	NULL

-	NULL
To	NULL
obtain	NULL
a	NULL
large	NULL
number	NULL
of	NULL
megakaryocytes	NULL
,	NULL
low-density	NULL
bone	NULL
marrow	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
suspension	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
%	NULL
aplastic	NULL
serum	NULL
(	NULL
serum	NULL
from	NULL
patients	NULL
having	NULL
undergone	NULL
a	NULL
bone	NULL
marrow	NULL
transplantation	NULL
)	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

After	NULL
7	NULL
to	NULL
14	NULL
days	NULL
in	NULL
culture	NULL
,	NULL
megakaryocytes	NULL
were	NULL
morphologically	NULL
identifiable	NULL
and	NULL
represented	NULL
5	NULL
%	NULL
to	NULL
25	NULL
%	NULL
of	NULL
the	NULL
cultured	NULL
cells	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
directly	NULL
used	NULL
for	NULL
in	NULL
situ	NULL
hybridization	NULL
or	NULL
further	NULL
purified	NULL
for	NULL
RNA	NULL
extraction	NULL
using	NULL
the	NULL
immunomagnetic	NULL
bead	NULL
technique	NULL
and	NULL
the	NULL
antiplatelet	NULL
glycoprotein	NULL
IIIa	NULL
MoAb	NULL
Y2-51.5	NULL
In	NULL
Situ	NULL
Hybridization	NULL
Preparation	NULL
of	NULL
riboprobes	NULL
.	NULL

-	NULL
Human	NULL
tal-1	NULL
cDNA	NULL
(	NULL
EcoRI	NULL
,	NULL
1.9	NULL
kb	NULL
)	NULL
,	NULL
the	NULL
5	NULL
end	NULL
of	NULL
human	NULL
GATA-1	NULL
cDNA	NULL
(	NULL
HindIII-Sa/l	NULL
0.6	NULL
kb	NULL
)	NULL
,	NULL
murine	NULL
,	NULL
B-actin	NULL
(	NULL
600	NULL
bp	NULL
)	NULL
,	NULL
and	NULL
A	NULL
bacteriophage	NULL
(	NULL
HindIII-EcoR1I	NULL
,	NULL
947	NULL
pb	NULL
)	NULL
were	NULL
subcloned	NULL
into	NULL
plasmids	NULL
that	NULL
contain	NULL
RNA	NULL
polymerase	NULL
promoter	NULL
sites	NULL
.	NULL

Run-off	NULL
transcripts	NULL
of	NULL
appropriate	NULL
linearized	NULL
plasmids	NULL
were	NULL
synthesized	NULL
using	NULL
either	NULL
77	NULL
,	NULL
SP6	NULL
,	NULL
or	NULL
T3	NULL
RNA	NULL
polymerase	NULL
in	NULL
a	NULL
reaction	NULL
containing	NULL
60	NULL
of	NULL
[	NULL
aÂ®Â°S	NULL
]	NULL
-UTP	NULL
(	NULL
1,200	NULL
Ci/mmol	NULL
)	NULL
(	NULL
Amersham	NULL
}	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instructions	NULL
(	NULL
Promega	NULL
Biotec	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
and	NULL
as	NULL
described	NULL
.	NULL
``	NULL

The	NULL
length	NULL
of	NULL
RNA	NULL
probes	NULL
was	NULL
adjusted	NULL
to	NULL
an	NULL
average	NULL
of	NULL
approximately	NULL
100	NULL
to	NULL
150	NULL
bases	NULL
by	NULL
limited	NULL
alkaline	NULL
hydrolysis	NULL
.	NULL

The	NULL
RNA	NULL
probes	NULL
were	NULL
of	NULL
similar	NULL
specific	NULL
activity	NULL
and	NULL
size	NULL
(	NULL
determined	NULL
by	NULL
gel	NULL
electrophoresis	NULL
under	NULL
denaturing	NULL
conditions	NULL
)	NULL
.	NULL

By	NULL
Northern	NULL
blot	NULL
,	NULL
the	NULL
1a/-1	NULL
P	NULL
antisense	NULL
riboprobe	NULL
showed	NULL
two	NULL
bands	NULL
at	NULL
the	NULL
correct	NULL
sizes	NULL
using	NULL
HEL	NULL
RNAs	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Cell	NULL
fixation	NULL
,	NULL
hybridization	NULL
,	NULL
and	NULL
washes	NULL
.	NULL

-	NULL
Experimental	NULL
conditions	NULL
for	NULL
fixation	NULL
,	NULL
hybridization	NULL
,	NULL
and	NULL
washes	NULL
were	NULL
as	NULL
described	NULL
previously	NULL
``	NULL
with	NULL
some	NULL
modifications	NULL
.	NULL
``	NULL

Cells	NULL
were	NULL
washed	NULL
,	NULL
cytocentrifuged	NULL
,	NULL
and	NULL
immediately	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
in	NULL
phosphate-buffered	NULL
saline	NULL
(	NULL
PBS	NULL
)	NULL
pH	NULL
7.4	NULL
for	NULL
3	NULL
minutes	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Preparations	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

tal-1	NULL
AND	NULL
GATA	NULL
GENE	NULL
EXPRESSION	NULL
IN	NULL
HEMATOPOIESIS	NULL
were	NULL
then	NULL
transferred	NULL
into	NULL
a	NULL
solution	NULL
of	NULL
70	NULL
%	NULL
ethanol	NULL
and	NULL
stored	NULL
at	NULL
4Â°C	NULL
until	NULL
use	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
postfixed	NULL
in	NULL
2	NULL
%	NULL
paraformaldehyde/	NULL
1	NULL
%	NULL
glutaraldehyde	NULL
(	NULL
Sigma	NULL
Chemical	NULL
Co	NULL
,	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
in	NULL
PBS	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
washed	NULL
in	NULL
PBS	NULL
,	NULL
acetylated	NULL
in	NULL
0.1	NULL
mmol/L	NULL
triethanol-amine/0.25	NULL
%	NULL
acetic	NULL
anhydride	NULL
(	NULL
pH	NULL
8	NULL
)	NULL
for	NULL
10	NULL
minutes	NULL
,	NULL
and	NULL
then	NULL
washed	NULL
in	NULL
PBS	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
deshydrated	NULL
in	NULL
successive	NULL
baths	NULL
of	NULL
ethanol	NULL
,	NULL
and	NULL
air	NULL
dried	NULL
.	NULL

Hybridization	NULL
was	NULL
performed	NULL
at	NULL
50Â°C	NULL
for	NULL
16	NULL
hours	NULL
with	NULL
10Â°	NULL
cpm/	NULL
uL	NULL
of	NULL
riboprobe	NULL
in	NULL
appropriate	NULL
buffer	NULL
.	NULL

Washes	NULL
were	NULL
performed	NULL
at	NULL
54Â°C	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
140	NULL
mmol/L	NULL
2-8-mercaptoethanol	NULL
and	NULL
successively	NULL
rinsed	NULL
in	NULL
baths	NULL
up	NULL
to	NULL
0.5	NULL
X	NULL
sodium	NULL
saline	NULL
citrate	NULL
(	NULL
SSC	NULL
)	NULL
,	NULL
dehydrated	NULL
in	NULL
ethanol	NULL
,	NULL
air	NULL
dried	NULL
,	NULL
and	NULL
coated	NULL
with	NULL
NTB2	NULL
emulsion	NULL
(	NULL
Eastman	NULL
Kodak	NULL
,	NULL
Marne	NULL
La	NULL
VallÃ©e	NULL
,	NULL
France	NULL
)	NULL
for	NULL
autoradiography	NULL
and	NULL
exposed	NULL
for	NULL
10	NULL
to	NULL
15	NULL
days	NULL
.	NULL

The	NULL
slides	NULL
were	NULL
counterstained	NULL
by	NULL
May-Griinwald-Giemsa	NULL
(	NULL
Merck	NULL
,	NULL
Darmstadt	NULL
,	NULL
Germany	NULL
)	NULL
and	NULL
examined	NULL
by	NULL
light	NULL
microscopy	NULL
.	NULL

The	NULL
number	NULL
of	NULL
silver	NULL
grains	NULL
were	NULL
counted	NULL
,	NULL
in	NULL
a	NULL
double	NULL
blind	NULL
study	NULL
,	NULL
on	NULL
a	NULL
minimum	NULL
of	NULL
30	NULL
cells	NULL
.	NULL

Reverse	NULL
Transcriptase-Polymerase	NULL
Chain	NULL
Reaction	NULL
(	NULL
RT-PCR	NULL
)	NULL
RNA	NULL
extraction	NULL
.	NULL

-	NULL
RNA	NULL
from	NULL
BFU-E-derived	NULL
colonies	NULL
,	NULL
purified	NULL
cultured	NULL
megakaryocytes	NULL
,	NULL
bone	NULL
marrow	NULL
,	NULL
fetal	NULL
liver	NULL
(	NULL
12	NULL
and	NULL
22	NULL
weeks	NULL
old	NULL
)	NULL
,	NULL
cells	NULL
from	NULL
leukemic	NULL
patients	NULL
,	NULL
peripheral	NULL
blood	NULL
cells	NULL
,	NULL
thymic	NULL
cells	NULL
,	NULL
platelets	NULL
,	NULL
and	NULL
cell	NULL
lines	NULL
were	NULL
extracted	NULL
as	NULL
described	NULL
.	NULL

*	NULL
Total	NULL
cytoplasmic	NULL
RNAs	NULL
from	NULL
CD34/CD38	NULL
purified	NULL
cells	NULL
were	NULL
extracted	NULL
as	NULL
described	NULL
.	NULL
``	NULL

PCR	NULL
experiments	NULL
.	NULL

-	NULL
First-strand	NULL
cDNA	NULL
was	NULL
synthesized	NULL
in	NULL
a	NULL
20-gL	NULL
reaction	NULL
containing	NULL
5	NULL
ug	NULL
total	NULL
RNA	NULL
or	NULL
total	NULL
RNA	NULL
from	NULL
4	NULL
x	NULL
10Â°	NULL
CD34/CD38	NULL
purified	NULL
cells	NULL
,	NULL
1	NULL
mmol/L	NULL
each	NULL
dNTP	NULL
,	NULL
BRL	NULL
reverse-tran-scriptase	NULL
buffer	NULL
,	NULL
30	NULL
U	NULL
of	NULL
Mu-MoLV	NULL
reverse-transcriptase	NULL
,	NULL
and	NULL
50	NULL
pmol	NULL
!	NULL

of	NULL
hexanucleotides	NULL
.	NULL

The	NULL
reaction	NULL
mix	NULL
was	NULL
incubated	NULL
at	NULL
42Â°C	NULL
for	NULL
60	NULL
minutes	NULL
.	NULL

Amplification	NULL
was	NULL
performed	NULL
``	NULL
by	NULL
diluting	NULL
0.5	NULL
gL	NULL
or	NULL
4	NULL
gL	NULL
for	NULL
CD34/CD38	NULL
purified	NULL
cells	NULL
,	NULL
of	NULL
first-strand	NULL
cDNA	NULL
into	NULL
49	NULL
gL	NULL
containing	NULL
100	NULL
amol/L	NULL
of	NULL
each	NULL
dNTP	NULL
,	NULL
50	NULL
mmol/L	NULL
KCI	NULL
,	NULL
10	NULL
mmol/	NULL
L	NULL
Tris	NULL
(	NULL
hydroxymethyl	NULL
)	NULL
-aminomethane	NULL
(	NULL
TRIS	NULL
,	NULL
pH	NULL
8	NULL
)	NULL
,	NULL
1.5	NULL
mmol/L	NULL
MgC1	NULL
;	NULL
,	NULL
0.01	NULL
%	NULL
(	NULL
wt/vol	NULL
)	NULL
gelatin	NULL
,	NULL
1	NULL
U	NULL
Taq	NULL
polymerase	NULL
(	NULL
Cetus	NULL
)	NULL
,	NULL
and	NULL
20	NULL
pmol	NULL
of	NULL
each	NULL
specific	NULL
primer	NULL
.	NULL

To	NULL
follow	NULL
the	NULL
reaction	NULL
,	NULL
0.15	NULL
gL	NULL
of	NULL
[	NULL
Â«	NULL
*P	NULL
]	NULL
-dCTP	NULL
(	NULL
New	NULL
England	NULL
Nuclear	NULL
;	NULL
NEN	NULL
)	NULL
was	NULL
added	NULL
.	NULL

The	NULL
samples	NULL
were	NULL
denaturated	NULL
by	NULL
heating	NULL
at	NULL
94Â°C	NULL
for	NULL
5	NULL
minutes	NULL
and	NULL
then	NULL
underwent	NULL
25	NULL
cycles	NULL
of	NULL
1	NULL
minute	NULL
at	NULL
94Â°C	NULL
,	NULL
1	NULL
minute	NULL
at	NULL
58Â°C	NULL
,	NULL
and	NULL
1.5	NULL
minutes	NULL
at	NULL
72Â°C	NULL
,	NULL
followed	NULL
by	NULL
10	NULL
minutes	NULL
at	NULL
72Â°C	NULL
after	NULL
the	NULL
last	NULL
cycle	NULL
.	NULL

Ten	NULL
microliters	NULL
of	NULL
PCR	NULL
products	NULL
was	NULL
migrated	NULL
on	NULL
a	NULL
5	NULL
%	NULL
to	NULL
10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
autoradiographed	NULL
for	NULL
1	NULL
day	NULL
with	NULL
screen	NULL
.	NULL

For	NULL
1A	NULL
promoter	NULL
analysis	NULL
,	NULL
the	NULL
gel	NULL
was	NULL
transfered	NULL
and	NULL
hybridized	NULL
with	NULL
a	NULL
specific	NULL
fal-1	NULL
probe	NULL
.	NULL

Specific	NULL
primers	NULL
for	NULL
human	NULL
genes	NULL
were	NULL
:	NULL
tal-1	NULL
[	NULL
Z1	NULL
1	NULL
;	NULL
5-TTGGGGAGCCGGATGCCTTC	NULL
(	NULL
forward	NULL
exon	NULL
5	NULL
)	NULL
.	NULL

tal-1/Z8	NULL
:	NULL
5-CTCCCGGCTGTTGGTGAA	NULL
(	NULL
backward	NULL
exon	NULL
6	NULL
)	NULL
tal-1	NULL
[	NULL
ZA	NULL
5-CGCTCAGGACCGGGCCTCAA	NULL
(	NULL
forward	NULL
exon	NULL
1A	NULL
)	NULL
tal-1/29	NULL
;	NULL
5-TGTGCATGCGGTGGGATTGT	NULL
(	NULL
forward	NULL
exon	NULL
1B	NULL
)	NULL
tal-1/Z13	NULL
;	NULL
5-GCGGAAGCCGAGGAAGAGGAT	NULL
(	NULL
backward	NULL
exon	NULL
3	NULL
)	NULL
GATA-1	NULL
:	NULL
5-CAGTAAACGAGCAGGTACTC	NULL
(	NULL
forward	NULL
808-827	NULL
)	NULL
1-ATAG	NULL
:	NULL
5-CATAAAGCCACCAGCTGGTC	NULL
(	NULL
backward	NULL
1063-1044	NULL
)	NULL
GATA-2	NULL
:	NULL
5-AGCCGGCACCTGTTGTGCAA	NULL
(	NULL
forward	NULL
1207-1226	NULL
)	NULL
2-ATAG	NULL
:	NULL
5-TGACTTCTCCTGCATGCACT	NULL
(	NULL
backward	NULL
1450-1431	NULL
)	NULL
GATA-3	NULL
:	NULL
5-GGGCTCTACTACAAG	NULL
(	NULL
forward	NULL
1225-1239	NULL
)	NULL
3-ATAG	NULL
:	NULL
5-GTCCTCCAGTGAGTCATGCAC	NULL
(	NULL
backward	NULL
1353-1333	NULL
)	NULL
The	NULL
G6PD	NULL
primers	NULL
were	NULL
as	NULL
described	NULL
by	NULL
Boehm	NULL
et	NULL
al	NULL
``	NULL
``	NULL
without	NULL
the	NULL
cloning	NULL
sites	NULL
.	NULL

649	NULL
RESULTS	NULL
In	NULL
situ	NULL
hybridization	NULL
.	NULL

-	NULL
It	NULL
has	NULL
been	NULL
reported	NULL
that	NULL
the	NULL
fal-1	NULL
gene	NULL
was	NULL
expressed	NULL
in	NULL
erythroleukemic	NULL
and	NULL
immature	NULL
myeloid	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
Additional	NULL
studies	NULL
on	NULL
a	NULL
large	NULL
survey	NULL
of	NULL
well-characterized	NULL
cell	NULL
lines	NULL
indicated	NULL
that	NULL
ta/-1	NULL
expression	NULL
also	NULL
occurred	NULL
in	NULL
mast	NULL
cell	NULL
lines	NULL
``	NULL
``	NULL
and	NULL
in	NULL
several	NULL
T-cell	NULL
lines	NULL
devoid	NULL
of	NULL
evident	NULL
tal-1	NULL
gene	NULL
alteration.Â®	NULL
``	NULL
``	NULL
However	NULL
,	NULL
all	NULL
these	NULL
studies	NULL
were	NULL
performed	NULL
with	NULL
human	NULL
and	NULL
murine	NULL
established	NULL
cell	NULL
lines	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
expression	NULL
of	NULL
fa/-1	NULL
in	NULL
the	NULL
hematopoietic	NULL
system	NULL
,	NULL
we	NULL
undertook	NULL
in	NULL
situ	NULL
hybridization	NULL
studies	NULL
on	NULL
normal	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

In	NULL
previous	NULL
studies	NULL
on	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
ta/-1	NULL
expression	NULL
appeared	NULL
to	NULL
resemble	NULL
that	NULL
of	NULL
the	NULL
specific	NULL
transcription	NULL
factor	NULL
Therefore	NULL
,	NULL
we	NULL
decided	NULL
to	NULL
perform	NULL
this	NULL
analysis	NULL
in	NULL
parallel	NULL
for	NULL
both	NULL
genes	NULL
.	NULL

Sense	NULL
riboprobes	NULL
and	NULL
an	NULL
irrelevant	NULL
probe	NULL
(	NULL
derived	NULL
from	NULL
A	NULL
phage	NULL
DNA	NULL
)	NULL
were	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
,	NULL
and	NULL
the	NULL
positive	NULL
control	NULL
was	NULL
an	NULL
antisense	NULL
B	NULL
actin	NULL
probe	NULL
.	NULL

In	NULL
the	NULL
first	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
presence	NULL
of	NULL
tal-1	NULL
transcripts	NULL
in	NULL
normal	NULL
bone	NULL
marrow	NULL
granulocytic	NULL
cells	NULL
{	NULL
(	NULL
myelocytes	NULL
,	NULL
metamyelocytes	NULL
,	NULL
and	NULL
polymorphs	NULL
)	NULL
.	NULL

The	NULL
number	NULL
of	NULL
silver	NULL
grains	NULL
observed	NULL
with	NULL
the	NULL
ta/-1	NULL
antisense	NULL
probe	NULL
did	NULL
not	NULL
exceed	NULL
that	NULL
obtained	NULL
with	NULL
different	NULL
negative	NULL
controls	NULL
.	NULL

Similarly	NULL
,	NULL
no	NULL
hybridization	NULL
could	NULL
be	NULL
detected	NULL
with	NULL
the	NULL
GATA-1	NULL
probe	NULL
,	NULL
whereas	NULL
a	NULL
clear	NULL
hybridization	NULL
was	NULL
obtained	NULL
with	NULL
the	NULL
B-actin	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
the	NULL
second	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
fa/-1	NULL
transcription	NULL
was	NULL
studied	NULL
in	NULL
peripheral	NULL
blood	NULL
lymphocytes	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
granulocytes	NULL
.	NULL

Among	NULL
granulocytes	NULL
,	NULL
only	NULL
neutrophilic	NULL
and	NULL
eosinophilic	NULL
cells	NULL
were	NULL
detected	NULL
on	NULL
the	NULL
slides	NULL
.	NULL

A	NULL
pattern	NULL
of	NULL
hybridization	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
bone	NULL
marrow	NULL
granulocytic	NULL
cells	NULL
was	NULL
observed	NULL
in	NULL
all	NULL
of	NULL
these	NULL
cell	NULL
types	NULL
(	NULL
ie	NULL
,	NULL
no	NULL
hybridization	NULL
with	NULL
ta/-1	NULL
and	NULL
GATA-1	NULL
antisense	NULL
probes	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
actin	NULL
probe	NULL
always	NULL
gave	NULL
a	NULL
signal	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

To	NULL
study	NULL
the	NULL
basophilic	NULL
lineage	NULL
,	NULL
blood	NULL
granulocytes	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
were	NULL
used	NULL
as	NULL
a	NULL
source	NULL
of	NULL
basophilic	NULL
granulocytes	NULL
.	NULL

Among	NULL
granulocytes	NULL
,	NULL
only	NULL
the	NULL
basophilic	NULL
ones	NULL
hybridized	NULL
with	NULL
the	NULL
ta/-1	NULL
probe	NULL
as	NULL
well	NULL
as	NULL
with	NULL
the	NULL
GATA-1	NULL
probe	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

To	NULL
check	NULL
that	NULL
we	NULL
were	NULL
not	NULL
confusing	NULL
silver	NULL
grains	NULL
and	NULL
cytoplasmic	NULL
granules	NULL
of	NULL
the	NULL
basophilic	NULL
granulocytes	NULL
,	NULL
several	NULL
slides	NULL
were	NULL
counterstained	NULL
with	NULL
toludine	NULL
blue	NULL
,	NULL
and	NULL
the	NULL
silver	NULL
grains	NULL
did	NULL
not	NULL
co-localize	NULL
with	NULL
the	NULL
coloration	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
these	NULL
basophilic	NULL
granulocytes	NULL
show	NULL
an	NULL
hybridization	NULL
signal	NULL
only	NULL
with	NULL
the	NULL
ta/-1	NULL
,	NULL
GATA-1	NULL
and	NULL
actin	NULL
probes	NULL
but	NULL
not	NULL
with	NULL
the	NULL
negative	NULL
control	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Low-density	NULL
marrow	NULL
cells	NULL
were	NULL
subsequently	NULL
analyzed	NULL
,	NULL
and	NULL
hybridization	NULL
with	NULL
the	NULL
fa/-1	NULL
antisense	NULL
probe	NULL
was	NULL
positive	NULL
in	NULL
a	NULL
minority	NULL
of	NULL
cells	NULL
that	NULL
could	NULL
be	NULL
classified	NULL
into	NULL
three	NULL
main	NULL
cytologic	NULL
types	NULL
:	NULL
first	NULL
,	NULL
cells	NULL
with	NULL
a	NULL
blast	NULL
morphology	NULL
(	NULL
repre-senting	NULL
less	NULL
than	NULL
1	NULL
%	NULL
of	NULL
the	NULL
low-density	NULL
marrow	NULL
cells	NULL
)	NULL
;	NULL
second	NULL
,	NULL
rare	NULL
megakaryocytes	NULL
present	NULL
on	NULL
smears	NULL
;	NULL
and	NULL
third	NULL
,	NULL
erythro-blast-like	NULL
cells	NULL
(	NULL
which	NULL
were	NULL
difficult	NULL
to	NULL
identify	NULL
because	NULL
their	NULL
cytoplasm	NULL
remained	NULL
unstained	NULL
despite	NULL
multiple	NULL
counter-staining	NULL
techniques	NULL
)	NULL
.	NULL

These	NULL
three	NULL
cell	NULL
types	NULL
were	NULL
also	NULL
positive	NULL
with	NULL
the	NULL
GATA-1	NULL
and	NULL
the	NULL
B-actin	NULL
probes	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Immature	NULL
marrow	NULL
cells	NULL
were	NULL
purified	NULL
by	NULL
an	NULL
antibody	NULL
anti-CD34	NULL
antigen	NULL
.	NULL

This	NULL
cell	NULL
population	NULL
was	NULL
contaminated	NULL
by	NULL
less	NULL
than	NULL
5	NULL
%	NULL
of	NULL
CD34~	NULL
cells	NULL
,	NULL
which	NULL
were	NULL
essentially	NULL
granu-	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

650	NULL
Erythro	NULL
.	NULL

CD34	NULL
+	NULL
tal-1	NULL
a	NULL
antisense	NULL
Q	NULL
~	NULL
.	NULL

GATA-1	NULL
_	NULL
f	NULL
antisense	NULL
.	NULL

tal-1	NULL
â	NULL
sense	NULL
mesi	NULL
?	NULL

MOUTHON	NULL
ET	NULL
AL	NULL
baso	NULL
.	NULL

granulo	NULL
.	NULL

Fig	NULL
1	NULL
.	NULL

-	NULL
Detection	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
of	NULL
ta/-7	NULL
and	NULL
GATA-1	NULL
mRNAs	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

CD34+	NULL
cells	NULL
were	NULL
isolated	NULL
from	NULL
bone	NULL
marrow	NULL
with	NULL
immunomagnetic	NULL
beads	NULL
.	NULL

Erythroblasts	NULL
(	NULL
Erythro	NULL
.	NULL
)	NULL

or	NULL
megakaryocytes	NULL
(	NULL
MK	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
cultures	NULL
.	NULL

Lymphocytes	NULL
and	NULL
monocytes	NULL
(	NULL
PBL	NULL
)	NULL
or	NULL
neutrophilic	NULL
and	NULL
eosinophilic	NULL
granulocytes	NULL
(	NULL
gran	NULL
.	NULL
)	NULL

and	NULL
basophilic	NULL
granulocytes	NULL
(	NULL
baso	NULL
.	NULL
)	NULL

were	NULL
isolated	NULL
from	NULL
peripheral	NULL
blood	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
hybridized	NULL
with	NULL
ta/-1	NULL
antisense	NULL
(	NULL
experimental	NULL
)	NULL
,	NULL
GATA-1	NULL
antisense	NULL
(	NULL
experimental	NULL
)	NULL
,	NULL
ta/-1	NULL
sense	NULL
(	NULL
negative	NULL
controls	NULL
)	NULL
,	NULL
and	NULL
B-actin	NULL
(	NULL
positive	NULL
control	NULL
)	NULL
Â°Â°S	NULL
riboprobes	NULL
.	NULL

After	NULL
10	NULL
to	NULL
15	NULL
days	NULL
of	NULL
exposure	NULL
,	NULL
cells	NULL
were	NULL
counterstained	NULL
by	NULL
May-Griunwald-Giemsa	NULL
coloration	NULL
.	NULL

Photographic	NULL
proofs	NULL
were	NULL
performed	NULL
under	NULL
light	NULL
microscopy	NULL
with	NULL
a	NULL
1,000	NULL
%	NULL
magnification	NULL
.	NULL

locytes	NULL
.	NULL

The	NULL
CD34*	NULL
population	NULL
contained	NULL
10	NULL
%	NULL
to	NULL
20	NULL
%	NULL
hematopoietic	NULL
progenitors	NULL
associated	NULL
with	NULL
immature	NULL
hematopoietic	NULL
precursors	NULL
.	NULL

Hybridization	NULL
was	NULL
quantified	NULL
by	NULL
counting	NULL
the	NULL
number	NULL
of	NULL
silver	NULL
grains	NULL
on	NULL
each	NULL
cell	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

About	NULL
20	NULL
%	NULL
of	NULL
CD34*	NULL
cells	NULL
clearly	NULL
expressed	NULL
transcripts	NULL
,	NULL
as	NULL
shown	NULL
by	NULL
at	NULL
least	NULL
a	NULL
twofold	NULL
to	NULL
threefold	NULL
increase	NULL
in	NULL
the	NULL
hybridization	NULL
level	NULL
over	NULL
the	NULL
two	NULL
negative	NULL
controls	NULL
(	NULL
the	NULL
sense	NULL
and	NULL
the	NULL
A	NULL
phage	NULL
probes	NULL
)	NULL
.	NULL

A	NULL
same	NULL
pattern	NULL
of	NULL
hybridization	NULL
was	NULL
obtained	NULL
with	NULL
GATA-1	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

To	NULL
obtain	NULL
a	NULL
pure	NULL
population	NULL
of	NULL
erythroblasts	NULL
,	NULL
pooled	NULL
BFU-E-derived	NULL
colonies	NULL
were	NULL
recovered	NULL
at	NULL
day	NULL
8	NULL
of	NULL
culture	NULL
and	NULL
investigated	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

fa/-1	NULL
Transcripts	NULL
were	NULL
detected	NULL
in	NULL
70	NULL
%	NULL
of	NULL
day-8	NULL
erythroblastic	NULL
cells	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
that	NULL
did	NULL
not	NULL
hybridize	NULL
with	NULL
the	NULL
probe	NULL
were	NULL
much	NULL
smaller	NULL
than	NULL
the	NULL
others	NULL
and	NULL
had	NULL
a	NULL
small	NULL
round	NULL
nucleus	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
,	NULL
but	NULL
their	NULL
morphology	NULL
remained	NULL
difficult	NULL
to	NULL
study	NULL
because	NULL
we	NULL
were	NULL
unable	NULL
to	NULL
counterstain	NULL
their	NULL
cytoplasm	NULL
.	NULL

Control	NULL
slides	NULL
,	NULL
therefore	NULL
,	NULL
were	NULL
stained	NULL
with	NULL
benzidine	NULL
and	NULL
15	NULL
%	NULL
of	NULL
these	NULL
cells	NULL
were	NULL
positive	NULL
.	NULL

We	NULL
compared	NULL
their	NULL
morphology	NULL
with	NULL
that	NULL
of	NULL
the	NULL
in	NULL
situ	NULL
hybridization	NULL
slides	NULL
,	NULL
and	NULL
identified	NULL
the	NULL
ta/-1-negative	NULL
cells	NULL
as	NULL
acidophilic	NULL
erythroblasts	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
level	NULL
of	NULL
tal-1	NULL
transcription	NULL
decreased	NULL
during	NULL
erythroid	NULL
maturation	NULL
.	NULL

This	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
studying	NULL
BFU-E-derived	NULL
colonies	NULL
at	NULL
later	NULL
days	NULL
of	NULL
culture	NULL
.	NULL

At	NULL
day	NULL
12	NULL
of	NULL
culture	NULL
,	NULL
when	NULL
60	NULL
%	NULL
of	NULL
erythroblasts	NULL
are	NULL
benzidine	NULL
positive	NULL
,	NULL
only	NULL
35	NULL
%	NULL
of	NULL
the	NULL
erythroblasts	NULL
hybridized	NULL
with	NULL
the	NULL
ra/-1	NULL
probe	NULL
.	NULL

In	NULL
parallel	NULL
,	NULL
a	NULL
decrease	NULL
of	NULL
GATA-1	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
acidophilic	NULL
erythro-blast	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

This	NULL
was	NULL
further	NULL
shown	NULL
by	NULL
a	NULL
decrease	NULL
of	NULL
the	NULL
specific	NULL
hybridization	NULL
with	NULL
GATA-1	NULL
probe	NULL
in	NULL
erythroblasts	NULL
from	NULL
65	NULL
%	NULL
at	NULL
day	NULL
8	NULL
to	NULL
35	NULL
%	NULL
at	NULL
day	NULL
12	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
fa/-1	NULL
antisense	NULL
hybridization	NULL
on	NULL
erythroblasts	NULL
was	NULL
checked	NULL
by	NULL
treating	NULL
the	NULL
cells	NULL
with	NULL
RNase	NULL
before	NULL
hybridization	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
pretreatment	NULL
of	NULL
cells	NULL
with	NULL
both	NULL
RNases	NULL
A	NULL
and	NULL
TI	NULL
diminished	NULL
the	NULL
hybridization	NULL
with	NULL
tal-1	NULL
antisense	NULL
to	NULL
the	NULL
level	NULL
obtained	NULL
with	NULL
the	NULL
negative	NULL
control	NULL
probes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
background	NULL
of	NULL
hybridization	NULL
obtained	NULL
with	NULL
both	NULL
negative	NULL
control	NULL
probes	NULL
was	NULL
not	NULL
modified	NULL
by	NULL
RNase	NULL
treatment	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
most	NULL
proeminent	NULL
hybridization	NULL
was	NULL
observed	NULL
on	NULL
megakaryocytes	NULL
obtained	NULL
after	NULL
10	NULL
days	NULL
of	NULL
culture	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

As	NULL
with	NULL
erythroblasts	NULL
,	NULL
a	NULL
larger	NULL
quantity	NULL
of	NULL
fa/-1	NULL
mRNA	NULL
was	NULL
expressed	NULL
in	NULL
the	NULL
immature	NULL
megakaryocytes	NULL
,	NULL
identified	NULL
by	NULL
their	NULL
basophilic	NULL
cytoplasm	NULL
and	NULL
obtained	NULL
at	NULL
day	NULL
7	NULL
of	NULL
culture	NULL
,	NULL
than	NULL
in	NULL
mature	NULL
megakaryocytes	NULL
obtained	NULL
at	NULL
day	NULL
10	NULL
of	NULL
culture	NULL
(	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

Similar	NULL
observations	NULL
were	NULL
found	NULL
with	NULL
the	NULL
GATA-1	NULL
probe	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
absolute	NULL
level	NULL
of	NULL
fa/-1	NULL
and	NULL
GATA-1	NULL
mRNA	NULL
per	NULL
cell	NULL
decreased	NULL
during	NULL
megakaryocytic	NULL
maturation	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

tal-1	NULL
AND	NULL
GATA	NULL
GENE	NULL
EXPRESSION	NULL
IN	NULL
HEMATOPOIESIS	NULL
100	NULL
a	NULL
-	NULL
801	NULL
Â§	NULL
Â§	NULL
67	NULL
$	NULL
00	NULL
404	NULL
c	NULL
&	NULL
-	NULL
2	NULL
]	NULL
o-0-19	NULL
20-39	NULL
40-59	NULL
>	NULL
60	NULL
Im	NULL
P	NULL
[	NULL
<	NULL
Â©	NULL
3	NULL
I	NULL
2	NULL
Â©	NULL
2	NULL
Â®	NULL
[	NULL
3	NULL
[	NULL
+4	NULL
0-9	NULL
10-419	NULL
20-20	NULL
30-39	NULL
40-49	NULL
>	NULL
50	NULL
100	NULL
C	NULL
Im	NULL
0	NULL
Â£	NULL
$	NULL
I	NULL
3	NULL
J	NULL
>	NULL
3	NULL
@	NULL
(	NULL
C	NULL
0-49	NULL
50-99	NULL
100-149	NULL
2150	NULL
Classes	NULL
of	NULL
silver	NULL
grains	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
Expression	NULL
of	NULL
tal-1	NULL
and	NULL
GATA-1	NULL
mRNAs	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

CD34*	NULL
(	NULL
A	NULL
}	NULL
,	NULL
erythroblasts	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
megakaryocytes	NULL
(	NULL
C	NULL
)	NULL
were	NULL
hybridized	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
section	NULL
with	NULL
ta/-1	NULL
sense	NULL
or	NULL
the	NULL
\	NULL
probe	NULL
(	NULL
white	NULL
column	NULL
)	NULL
as	NULL
negative	NULL
controls	NULL
or	NULL
ta/-1	NULL
antisense	NULL
(	NULL
black	NULL
column	NULL
)	NULL
and	NULL
GATA-1	NULL
antisense	NULL
(	NULL
gray	NULL
column	NULL
)	NULL
riboprobes	NULL
.	NULL

The	NULL
number	NULL
of	NULL
silver	NULL
grains	NULL
were	NULL
counted	NULL
on	NULL
more	NULL
than	NULL
30	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
classified	NULL
into	NULL
several	NULL
classes	NULL
according	NULL
to	NULL
their	NULL
number	NULL
of	NULL
silver	NULL
grains	NULL
.	NULL

The	NULL
relative	NULL
frequency	NULL
of	NULL
cells	NULL
in	NULL
each	NULL
class	NULL
was	NULL
calculated	NULL
and	NULL
represented	NULL
as	NULL
mean	NULL
+	NULL
standard	NULL
deviation	NULL
(	NULL
error	NULL
bars	NULL
)	NULL
of	NULL
three	NULL
repeated	NULL
in	NULL
situ	NULL
hybridization	NULL
experiments	NULL
.	NULL

PCR	NULL
experiments	NULL
.	NULL

-	NULL
We	NULL
undertook	NULL
the	NULL
characterization	NULL
of	NULL
tal-1	NULL
transcripts	NULL
in	NULL
different	NULL
cell	NULL
populations	NULL
derived	NULL
from	NULL
normal	NULL
bone	NULL
marrow	NULL
and	NULL
hematopoietic	NULL
tissues	NULL
.	NULL

f	NULL
@	NULL
/-1	NULL
Transcription	NULL
was	NULL
studied	NULL
by	NULL
PCR	NULL
analysis	NULL
on	NULL
mRNA	NULL
,	NULL
as	NULL
already	NULL
described	NULL
.	NULL
``	NULL

To	NULL
ascertain	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
RNA	NULL
samples	NULL
and	NULL
to	NULL
monitor	NULL
the	NULL
PCR	NULL
product	NULL
level	NULL
,	NULL
the	NULL
housekeeping	NULL
gene	NULL
,	NULL
glucose-6-phosphate	NULL
dehydrogenase	NULL
(	NULL
GGPD	NULL
)	NULL
,	NULL
was	NULL
used	NULL
as	NULL
an	NULL
internal	NULL
standard	NULL
during	NULL
PCR	NULL
reactions	NULL
.	NULL

In	NULL
a	NULL
first	NULL
set	NULL
of	NULL
experiments	NULL
,	NULL
we	NULL
chose	NULL
two	NULL
fa/-1	NULL
primers	NULL
(	NULL
Z8	NULL
and	NULL
Z11	NULL
)	NULL
,	NULL
which	NULL
amplify	NULL
the	NULL
bHLH	NULL
domain	NULL
sequences	NULL
present	NULL
in	NULL
all	NULL
fal-1	NULL
mRNA	NULL
species	NULL
described	NULL
so	NULL
far	NULL
.	NULL
``	NULL

''	NULL
For	NULL
this	NULL
analysis	NULL
,	NULL
we	NULL
used	NULL
a	NULL
series	NULL
of	NULL
RNAs	NULL
extracted	NULL
from	NULL
normal	NULL
hematopoietic	NULL
tissues	NULL
(	NULL
bone	NULL
marrow	NULL
,	NULL
thymus	NULL
,	NULL
fetal	NULL
liver	NULL
)	NULL
,	NULL
from	NULL
normal	NULL
purified	NULL
cell	NULL
populations	NULL
(	NULL
erythroblasts	NULL
,	NULL
megakaryocytes	NULL
,	NULL
CD34*	NULL
cells	NULL
from	NULL
bone	NULL
marrow	NULL
,	NULL
peripheral	NULL
blood	NULL
granulocytes	NULL
)	NULL
,	NULL
from	NULL
leukemic	NULL
samples	NULL
,	NULL
and	NULL
from	NULL
well-char-	NULL
651	NULL
acterized	NULL
hematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

The	NULL
resulting	NULL
autoradio-gram	NULL
is	NULL
presented	NULL
on	NULL
Fig	NULL
4	NULL
and	NULL
summarized	NULL
on	NULL
Table	NULL
1	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
a	NULL
specific	NULL
ta/-1	NULL
fragment	NULL
(	NULL
134	NULL
bp	NULL
)	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
lane	NULL
corresponding	NULL
to	NULL
cell	NULL
line	NULL
HEL	NULL
(	NULL
erythroid/mega-karyocyte	NULL
)	NULL
RNA	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

This	NULL
fragment	NULL
was	NULL
also	NULL
found	NULL
in	NULL
the	NULL
lanes	NULL
corresponding	NULL
to	NULL
the	NULL
pluripotent	NULL
UT-7	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
erythroid	NULL
K562	NULL
cell	NULL
line	NULL
,	NULL
the	NULL
erythroid/	NULL
megakaryocyte	NULL
CMK	NULL
,	NULL
Dami	NULL
,	NULL
and	NULL
Meg-01	NULL
cell	NULL
lines	NULL
,	NULL
the	NULL
Nalm-6	NULL
pre-B-cell	NULL
line	NULL
,	NULL
and	NULL
to	NULL
T-cell	NULL
lines	NULL
without	NULL
fa/-1	NULL
rearrangement	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
PCR	NULL
product	NULL
was	NULL
amplified	NULL
from	NULL
the	NULL
Raji	NULL
B-cell	NULL
line	NULL
RNA	NULL
used	NULL
as	NULL
negative	NULL
control	NULL
.	NULL

A	NULL
clear	NULL
expression	NULL
was	NULL
also	NULL
observed	NULL
in	NULL
samples	NULL
from	NULL
acute	NULL
megakaryoblastic	NULL
(	NULL
GEHE	NULL
)	NULL
,	NULL
chronic	NULL
myelogenous	NULL
leukemias	NULL
(	NULL
HAH	NULL
)	NULL
,	NULL
M4	NULL
leukemia	NULL
(	NULL
GAU	NULL
)	NULL
,	NULL
and	NULL
in	NULL
most	NULL
cases	NULL
of	NULL
T-ALL	NULL
devoid	NULL
of	NULL
ta/-1	NULL
gene	NULL
rearrangement	NULL
.	NULL

In	NULL
normal	NULL
tissue	NULL
,	NULL
a	NULL
clear	NULL
expression	NULL
was	NULL
observed	NULL
in	NULL
fetal	NULL
liver	NULL
cells	NULL
at	NULL
12	NULL
and	NULL
22	NULL
weeks	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
total	NULL
bone	NULL
marrow	NULL
.	NULL

In	NULL
purified	NULL
normal	NULL
cells	NULL
,	NULL
fa/-1	NULL
expression	NULL
was	NULL
evident	NULL
in	NULL
erythroblasts	NULL
obtained	NULL
from	NULL
8-day	NULL
cultures	NULL
,	NULL
megakaryocytes	NULL
obtained	NULL
from	NULL
10-day	NULL
cultures	NULL
,	NULL
and	NULL
in	NULL
CD34*	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
mirrored	NULL
those	NULL
of	NULL
the	NULL
in	NULL
situ	NULL
hybridization	NULL
experiments	NULL
.	NULL

PCR	NULL
product	NULL
was	NULL
also	NULL
detected	NULL
in	NULL
platelets	NULL
and	NULL
in	NULL
peripheral	NULL
blood	NULL
granulocytes	NULL
.	NULL

As	NULL
in	NULL
results	NULL
obtained	NULL
previously	NULL
,	NULL
no	NULL
ta/-1	NULL
PCR	NULL
product	NULL
was	NULL
detected	NULL
in	NULL
circulating	NULL
B	NULL
cells	NULL
or	NULL
T	NULL
cells	NULL
.	NULL

A	NULL
faint	NULL
transcription	NULL
was	NULL
visible	NULL
in	NULL
thymus	NULL
,	NULL
including	NULL
low-density	NULL
thymic	NULL
cells	NULL
(	NULL
96	NULL
%	NULL
of	NULL
T	NULL
cells	NULL
)	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
only	NULL
a	NULL
minor	NULL
subpopulation	NULL
of	NULL
thymic	NULL
cells	NULL
expresses	NULL
ta/-1	NULL
gene	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
the	NULL
data	NULL
of	NULL
this	NULL
assay	NULL
were	NULL
in	NULL
total	NULL
accordance	NULL
with	NULL
those	NULL
of	NULL
in	NULL
situ	NULL
hybridization	NULL
experiments	NULL
.	NULL

The	NULL
tal-1	NULL
gene	NULL
displays	NULL
a	NULL
complex	NULL
pattern	NULL
of	NULL
transcription	NULL
.	NULL

Indeed	NULL
,	NULL
multiple	NULL
mRNA	NULL
species	NULL
have	NULL
been	NULL
identified	NULL
which	NULL
60	NULL
7	NULL
#	NULL
-	NULL
501	NULL
:	NULL
<	NULL
$	NULL
-	NULL
401	NULL
8	NULL
.	NULL

4	NULL
E	NULL
301	NULL
m	NULL
|	NULL
3	NULL
-	NULL
207	NULL
2	NULL
4	NULL
(	NULL
E	NULL
10	NULL
7	NULL
0	NULL
0-49	NULL
50-99	NULL
100-149	NULL
>	NULL
150	NULL
Classes	NULL
of	NULL
silver	NULL
grains	NULL
Fig	NULL
3	NULL
.	NULL

Decrease	NULL
of	NULL
ta/-1	NULL
expression	NULL
during	NULL
megakaryocytic	NULL
differentiation	NULL
.	NULL

Megakaryocytes	NULL
(	NULL
MK	NULL
)	NULL
were	NULL
obtained	NULL
from	NULL
bone	NULL
marrow	NULL
cultures	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
platelet-poor	NULL
plasma	NULL
derived	NULL
from	NULL
patients	NULL
with	NULL
aplastic	NULL
marrow	NULL
.	NULL

Cells	NULL
were	NULL
fixed	NULL
after	NULL
7	NULL
days	NULL
(	NULL
black	NULL
column	NULL
}	NULL
,	NULL
10	NULL
days	NULL
(	NULL
gray	NULL
column	NULL
}	NULL
,	NULL
and	NULL
14	NULL
days	NULL
(	NULL
white	NULL
column	NULL
}	NULL
of	NULL
culture	NULL
.	NULL

The	NULL
frequency	NULL
of	NULL
morphologically	NULL
identifiable	NULL
immature	NULL
megakaryocytes	NULL
(	NULL
small	NULL
size	NULL
and	NULL
with	NULL
basophilic	NULL
staining	NULL
)	NULL
decreased	NULL
from	NULL
80	NULL
%	NULL
to	NULL
50	NULL
%	NULL
between	NULL
day	NULL
7	NULL
and	NULL
day	NULL
14	NULL
of	NULL
culture	NULL
.	NULL

These	NULL
cells	NULL
were	NULL
probed	NULL
for	NULL
ta/-1	NULL
expression	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Results	NULL
are	NULL
obtained	NULL
as	NULL
described	NULL
in	NULL
the	NULL
legend	NULL
of	NULL
Fig	NULL
2	NULL
from	NULL
three	NULL
repeated	NULL
experiments	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

652	NULL
MOUTHON	NULL
ET	NULL
AL	NULL
GGPD	NULL
ip	NULL
Â»	NULL
|Win	NULL
waee	NULL
tal-	NULL
Â»	NULL
Fig	NULL
4	NULL
.	NULL

-	NULL
PCR	NULL
analysis	NULL
of	NULL
ta/-1	NULL
mRNAs	NULL
.	NULL

cDNA	NULL
was	NULL
prepared	NULL
from	NULL
each	NULL
RNA	NULL
sample	NULL
and	NULL
used	NULL
for	NULL
PCR	NULL
reaction	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
[	NULL
a*Â°P	NULL
]	NULL
-dCTP	NULL
and	NULL
ta/-1	NULL
primers	NULL
Z11	NULL
(	NULL
forward	NULL
exon	NULL
5	NULL
)	NULL
and	NULL
28	NULL
(	NULL
back	NULL
exon	NULL
6	NULL
)	NULL
.	NULL

Internal	NULL
PCR	NULL
control	NULL
was	NULL
obtained	NULL
using	NULL
a	NULL
couple	NULL
of	NULL
primers	NULL
specific	NULL
for	NULL
G6PD	NULL
sequences	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
PCR	NULL
reaction	NULL
were	NULL
separated	NULL
by	NULL
polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
autoradiographed	NULL
overnight	NULL
.	NULL

(	NULL
Top	NULL
)	NULL
RNAs	NULL
from	NULL
human	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
:	NULL
FL	NULL
,	NULL
Fetal	NULL
liver	NULL
(	NULL
12	NULL
weeks	NULL
and	NULL
22	NULL
weeks	NULL
)	NULL
;	NULL
BM	NULL
,	NULL
bone	NULL
marrow	NULL
;	NULL
Tot	NULL
Thym	NULL
,	NULL
total	NULL
thymus	NULL
;	NULL
Fic	NULL
Thym	NULL
,	NULL
low-density	NULL
thymic	NULL
cells	NULL
;	NULL
Platel	NULL
,	NULL
Platelets	NULL
;	NULL
Erythr	NULL
,	NULL
erythroblasts	NULL
derived	NULL
from	NULL
BFU-E	NULL
;	NULL
MK	NULL
,	NULL
megakaryocytes	NULL
purified	NULL
from	NULL
bone	NULL
marrow	NULL
cultures	NULL
;	NULL
CD34*	NULL
,	NULL
CD34*	NULL
cells	NULL
purified	NULL
from	NULL
bone	NULL
marrow	NULL
;	NULL
granul	NULL
,	NULL
peripheral	NULL
blood	NULL
granulocytes	NULL
;	NULL
IL-2-PBL	NULL
,	NULL
Peripheral	NULL
blood	NULL
leukocytes	NULL
stimulated	NULL
by	NULL
IL-2	NULL
.	NULL

(	NULL
Bottom	NULL
)	NULL
RNAs	NULL
from	NULL
leukemic	NULL
patients	NULL
:	NULL
109	NULL
,	NULL
LAR	NULL
,	NULL
BUF	NULL
,	NULL
FOR	NULL
,	NULL
T-ALLs	NULL
without	NULL
evident	NULL
ta/-1	NULL
rearrangement	NULL
;	NULL
GEHE	NULL
,	NULL
acute	NULL
megakaryoblastic	NULL
leukemia	NULL
;	NULL
HAH	NULL
,	NULL
chronic	NULL
myeloid	NULL
leukemia	NULL
.	NULL

RNA	NULL
from	NULL
human	NULL
cell	NULL
lines	NULL
:	NULL
Jurkat	NULL
,	NULL
SKW3	NULL
,	NULL
REX	NULL
:	NULL
T	NULL
cells	NULL
;	NULL
K562	NULL
:	NULL
erythroid	NULL
;	NULL
HEL	NULL
,	NULL
Meg-01	NULL
,	NULL
Dami	NULL
,	NULL
CMK	NULL
:	NULL
erythroid/MK	NULL
;	NULL
Nalm-6	NULL
:	NULL
pre-B	NULL
;	NULL
Raji	NULL
:	NULL
Burkitt	NULL
lymphoma	NULL
;	NULL
UT-7	NULL
:	NULL
pluripotent	NULL
.	NULL

are	NULL
initiated	NULL
at	NULL
two	NULL
different	NULL
first	NULL
exons	NULL
(	NULL
1A	NULL
and	NULL
1B	NULL
)	NULL
and	NULL
produced	NULL
by	NULL
alternative	NULL
exon	NULL
utilization.Â®	NULL
``	NULL
*	NULL
Previous	NULL
study	NULL
on	NULL
leukemic	NULL
cell	NULL
lines	NULL
had	NULL
suggested	NULL
that	NULL
the	NULL
pattern	NULL
of	NULL
utilization	NULL
of	NULL
the	NULL
two	NULL
promoters	NULL
was	NULL
cell	NULL
lineage	NULL
dependent	NULL
.	NULL
``	NULL

To	NULL
identify	NULL
which	NULL
promoter	NULL
was	NULL
actually	NULL
active	NULL
in	NULL
the	NULL
various	NULL
hematopoietic	NULL
lineages	NULL
,	NULL
we	NULL
performed	NULL
RT-PCR	NULL
experiments	NULL
using	NULL
two	NULL
different	NULL
couples	NULL
of	NULL
primers	NULL
,	NULL
ZA/Z8	NULL
and	NULL
Z13/29	NULL
,	NULL
which	NULL
allowed	NULL
us	NULL
to	NULL
identify	NULL
transcripts	NULL
initiated	NULL
respectively	NULL
at	NULL
1A	NULL
and	NULL
1B	NULL
.	NULL

The	NULL
results	NULL
are	NULL
presented	NULL
on	NULL
Table	NULL
1	NULL
.	NULL

The	NULL
1A	NULL
promoter	NULL
is	NULL
used	NULL
in	NULL
all	NULL
normal	NULL
and	NULL
leukemic	NULL
cells	NULL
derived	NULL
from	NULL
the	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
and	NULL
in	NULL
Nalm-6	NULL
(	NULL
pre-B	NULL
)	NULL
,	NULL
but	NULL
it	NULL
is	NULL
not	NULL
used	NULL
in	NULL
T-cell	NULL
lineage	NULL
except	NULL
in	NULL
one	NULL
case	NULL
of	NULL
T-ALL	NULL
(	NULL
patient	NULL
BUF	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
1B	NULL
promoter	NULL
is	NULL
used	NULL
by	NULL
both	NULL
lymphoid	NULL
and	NULL
erythroid	NULL
cells	NULL
,	NULL
whereas	NULL
it	NULL
is	NULL
not	NULL
used	NULL
in	NULL
granulocytic	NULL
and	NULL
megakaryocytic	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
to	NULL
check	NULL
whether	NULL
fa/-1	NULL
was	NULL
co-expressed	NULL
with	NULL
GATA-1	NULL
or	NULL
with	NULL
other	NULL
GATA	NULL
genes	NULL
in	NULL
early	NULL
hematopoiesis	NULL
,	NULL
CD34Â°*/CD38~	NULL
,	NULL
CD34*/CD38Â®Â¢	NULL
,	NULL
and	NULL
CD34~	NULL
cells	NULL
were	NULL
sorted	NULL
and	NULL
probed	NULL
by	NULL
RT-PCR	NULL
for	NULL
ia/-1	NULL
and	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
and	NULL
GATA-3	NULL
genes	NULL
.	NULL

``	NULL
*	NULL
``	NULL
'	NULL
Two	NULL
independent	NULL
experiments	NULL
were	NULL
performed	NULL
and	NULL
gave	NULL
identical	NULL
results	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
.	NULL

The	NULL
fa/-1	NULL
and	NULL
GATA-1	NULL
transcripts	NULL
were	NULL
present	NULL
in	NULL
and	NULL
CD34~	NULL
cells	NULL
,	NULL
whereas	NULL
they	NULL
were	NULL
not	NULL
detectable	NULL
in	NULL
CD34Â°*/	NULL
CD38~	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GATA-2	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
three	NULL
cell	NULL
populations	NULL
but	NULL
in	NULL
larger	NULL
amount	NULL
in	NULL
the	NULL
two	NULL
CD34	NULL
*	NULL
cell	NULL
populations	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
GATA-3	NULL
is	NULL
strongly	NULL
expressed	NULL
in	NULL
CD34	NULL
,	NULL
cells	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
in	NULL
CD34Â°*/CD38~	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
Despite	NULL
the	NULL
frequent	NULL
involvement	NULL
of	NULL
the	NULL
fa/-1	NULL
gene	NULL
in	NULL
T-cell	NULL
malignancies	NULL
,	NULL
its	NULL
expression	NULL
has	NULL
not	NULL
been	NULL
detected	NULL
in	NULL
peripheral	NULL
T-cell	NULL
organs	NULL
(	NULL
PBL	NULL
,	NULL
lymph	NULL
nodes	NULL
)	NULL
but	NULL
in	NULL
hematopoietic	NULL
tissues	NULL
,	NULL
which	NULL
suggests	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
fa/-1	NULL
in	NULL
a	NULL
T-cell	NULL
clone	NULL
may	NULL
be	NULL
an	NULL
oncogenic	NULL
event	NULL
.	NULL

Several	NULL
sets	NULL
of	NULL
evidence	NULL
indicate	NULL
that	NULL
fa/-1	NULL
expression	NULL
is	NULL
related	NULL
to	NULL
normal	NULL
erythroid	NULL
differentiation	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
normal	NULL
tissues	NULL
,	NULL
it	NULL
has	NULL
until	NULL
now	NULL
only	NULL
been	NULL
detected	NULL
at	NULL
high	NULL
levels	NULL
in	NULL
fetal	NULL
liver	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a/-1	NULL
transcription	NULL
was	NULL
described	NULL
in	NULL
human	NULL
and	NULL
murine	NULL
erythroid	NULL
leukemic	NULL
cell	NULL
lines	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
mast	NULL
and	NULL
early	NULL
myeloid	NULL
leukemic	NULL
cell	NULL
lines	NULL
.	NULL

However	NULL
,	NULL
it	NULL
seemed	NULL
important	NULL
to	NULL
study	NULL
/a/-1	NULL
expression	NULL
in	NULL
normal	NULL
cells	NULL
for	NULL
two	NULL
rea-sons	NULL
.	NULL

First	NULL
,	NULL
the	NULL
putative	NULL
fa/-1	NULL
oncogene	NULL
may	NULL
be	NULL
abnormally	NULL
expressed	NULL
in	NULL
a	NULL
malignant	NULL
cell	NULL
line	NULL
,	NULL
where	NULL
it	NULL
is	NULL
assumed	NULL
to	NULL
participate	NULL
in	NULL
the	NULL
leukemic	NULL
process	NULL
.	NULL

Second	NULL
,	NULL
many	NULL
cell	NULL
lines	NULL
have	NULL
an	NULL
aberrant	NULL
phenotype	NULL
that	NULL
renders	NULL
them	NULL
difficult	NULL
to	NULL
compare	NULL
with	NULL
normal	NULL
differentiation	NULL
.	NULL

This	NULL
is	NULL
particularly	NULL
true	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

tal-1	NULL
AND	NULL
GATA	NULL
GENE	NULL
EXPRESSION	NULL
IN	NULL
HEMATOPOIESIS	NULL
Table	NULL
1	NULL
.	NULL

RT-PCR	NULL
Analysis	NULL
of	NULL
ta/-1	NULL
Transcription	NULL
in	NULL
Hematopoietic	NULL
Cells	NULL
Sample	NULL
Ex	NULL
5-Ex	NULL
6Â°	NULL
Ex	NULL
1A-Ex	NULL
6t	NULL
Ex	NULL
1B-Ex	NULL
3+	NULL
Normal	NULL
cells	NULL
Bone	NULL
marrow	NULL
Fetal	NULL
liver	NULL
Total	NULL
thymus	NULL
Low-density	NULL
thymic	NULL
cells	NULL
Megakaryocytes	NULL
Platelets	NULL
Erythroblasts	NULL
CD34	NULL
*	NULL
(	NULL
BM	NULL
)	NULL
Peripheral	NULL
granulocytes	NULL
PBL	NULL
(	NULL
PHA	NULL
stimulated	NULL
)	NULL
Cell	NULL
lines	NULL
Nalm-6	NULL
(	NULL
pre-B	NULL
)	NULL
UT-7	NULL
(	NULL
pluripotent	NULL
)	NULL
K562	NULL
(	NULL
erythroid	NULL
)	NULL
HEL	NULL
(	NULL
erythro/MK	NULL
)	NULL
Meg-0	NULL
1	NULL
(	NULL
erythro/MK	NULL
)	NULL
CMK	NULL
(	NULL
erythro/MK	NULL
)	NULL
Dami	NULL
(	NULL
erythro/MK	NULL
)	NULL
MOLT-4	NULL
(	NULL
T-cell	NULL
)	NULL
Jurkat	NULL
(	NULL
T-cell	NULL
)	NULL
REX	NULL
(	NULL
T-cell	NULL
)	NULL
SKW3	NULL
(	NULL
T-cell	NULL
)	NULL
HL	NULL
60	NULL
(	NULL
``	NULL
promyelocytic	NULL
``	NULL
)	NULL
Raji	NULL
(	NULL
B	NULL
lymphoma	NULL
)	NULL
Leukemic	NULL
patients	NULL
HAH	NULL
(	NULL
CML	NULL
)	NULL
GEHE	NULL
(	NULL
M7	NULL
)	NULL
109	NULL
(	NULL
T-ALL	NULL
)	NULL
$	NULL
FOR	NULL
(	NULL
T-ALL	NULL
)	NULL
Â§	NULL
BUF	NULL
(	NULL
T-ALL	NULL
)	NULL
Â§	NULL
LAR	NULL
(	NULL
T-ALL	NULL
)	NULL
Â§	NULL
GAU	NULL
(	NULL
M4	NULL
)	NULL
+	NULL
+	NULL
|I	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+o	NULL
t	NULL
t+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
4+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
I	NULL
M	NULL
I	NULL
I	NULL
I	NULL
I	NULL
+	NULL
1	NULL
+	NULL
++	NULL
+	NULL
+	NULL
+	NULL
+o	NULL
+	NULL
+	NULL
+	NULL
+o	NULL
t+	NULL
t	NULL
t+	NULL
+o	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+o	NULL
+	NULL
1	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
I	NULL
+	NULL
Abbreviation	NULL
:	NULL
ND	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

Â®	NULL
tal-1	NULL
Primers	NULL
Z11	NULL
and	NULL
28.	NULL
t	NULL
tal-1	NULL
Primers	NULL
ZA	NULL
and	NULL
28.	NULL
t	NULL
tal-1	NULL
Primers	NULL
Z9	NULL
and	NULL
213	NULL
.	NULL

$	NULL
T-ALL	NULL
without	NULL
evident	NULL
ta/-1	NULL
gene	NULL
rearrangement	NULL
.	NULL

for	NULL
the	NULL
HEL	NULL
cell	NULL
line	NULL
,	NULL
in	NULL
which	NULL
a	NULL
high	NULL
level	NULL
of	NULL
ta/-1	NULL
mRNA	NULL
is	NULL
found	NULL
and	NULL
that	NULL
expresses	NULL
simultaneously	NULL
many	NULL
specific	NULL
erythroid	NULL
and	NULL
megakaryocytic	NULL
differentiation	NULL
markers	NULL
.	NULL

By	NULL
studying	NULL
normal	NULL
hematopoietic	NULL
cells	NULL
,	NULL
it	NULL
was	NULL
possible	NULL
to	NULL
demonstrate	NULL
both	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
and	NULL
RT-PCR	NULL
that	NULL
tal-1	NULL
mRNA	NULL
was	NULL
present	NULL
in	NULL
normal	NULL
erythroid	NULL
cells	NULL
.	NULL

Its	NULL
expression	NULL
clearly	NULL
decreased	NULL
with	NULL
differentiation	NULL
.	NULL

This	NULL
result	NULL
contrasts	NULL
with	NULL
those	NULL
observed	NULL
during	NULL
induction	NULL
of	NULL
differentiation	NULL
of	NULL
murine	NULL
erythroleukemic	NULL
cell	NULL
lines	NULL
by	NULL
dimethyl	NULL
sulf-oxide	NULL
(	NULL
DMSO	NULL
)	NULL
,	NULL
which	NULL
was	NULL
associated	NULL
with	NULL
a	NULL
high	NULL
increase	NULL
in	NULL
the	NULL
fal-1	NULL
mRNA	NULL
level	NULL
.	NULL
``	NULL

This	NULL
rise	NULL
of	NULL
fa/-1	NULL
transcription	NULL
was	NULL
not	NULL
an	NULL
early	NULL
event	NULL
because	NULL
it	NULL
reached	NULL
a	NULL
maximum	NULL
after	NULL
4	NULL
days	NULL
of	NULL
induction	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
in	NULL
the	NULL
human	NULL
erythroleukemic	NULL
cell	NULL
line	NULL
K562	NULL
,	NULL
tal/-1	NULL
gene	NULL
product	NULL
seems	NULL
to	NULL
have	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
self-renewal	NULL
capacities	NULL
of	NULL
leukemic	NULL
cells	NULL
and	NULL
its	NULL
inhibition	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
differentiation	NULL
of	NULL
the	NULL
cell	NULL
line	NULL
.	NULL
``	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
results	NULL
show	NULL
that	NULL
fa/-1	NULL
mRNA	NULL
is	NULL
also	NULL
expressed	NULL
during	NULL
megakaryocytic	NULL
differentiation	NULL
and	NULL
that	NULL
its	NULL
653	NULL
absolute	NULL
level	NULL
per	NULL
cell	NULL
decreased	NULL
during	NULL
differentiation	NULL
,	NULL
although	NULL
it	NULL
is	NULL
still	NULL
present	NULL
in	NULL
platelets	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
detected	NULL
the	NULL
transcript	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
in	NULL
basophilic	NULL
granulocytes	NULL
from	NULL
a	NULL
patient	NULL
with	NULL
chronic	NULL
myelogenous	NULL
leukemia	NULL
,	NULL
whereas	NULL
it	NULL
was	NULL
not	NULL
detected	NULL
in	NULL
neutrophilic	NULL
and	NULL
eosinophilic	NULL
granulocytes	NULL
.	NULL

This	NULL
result	NULL
suggests	NULL
that	NULL
the	NULL
transcripts	NULL
detected	NULL
by	NULL
RT-PCR	NULL
in	NULL
peripheral	NULL
blood	NULL
granulocytes	NULL
are	NULL
related	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
tal-1	NULL
gene	NULL
transcripts	NULL
in	NULL
normal	NULL
basophils	NULL
.	NULL

In	NULL
the	NULL
mouse	NULL
,	NULL
1a/-1	NULL
transcripts	NULL
were	NULL
detected	NULL
in	NULL
mast	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
tal-1	NULL
GATA-1	NULL
GATA-2	NULL
GATA-3	NULL
coro	NULL
-	NULL
hase	NULL
exe	NULL
eat	NULL
)	NULL
Fig	NULL
5	NULL
.	NULL

-	NULL
PCR	NULL
analysis	NULL
of	NULL
the	NULL
ta/-1	NULL
and	NULL
the	NULL
three	NULL
GATA	NULL
genes	NULL
.	NULL

cDNA	NULL
was	NULL
prepared	NULL
from	NULL
total	NULL
RNA	NULL
extracted	NULL
with	NULL
4	NULL
x	NULL
10Â°	NULL
cells	NULL
sorted	NULL
by	NULL
flow	NULL
cytometry	NULL
on	NULL
their	NULL
expression	NULL
of	NULL
CD34	NULL
and	NULL
CD38	NULL
or	NULL
from	NULL
500	NULL
ng	NULL
of	NULL
total	NULL
RNA	NULL
of	NULL
CD34~	NULL
cells	NULL
.	NULL

PCR	NULL
for	NULL
ta/-1	NULL
and	NULL
GATA-1	NULL
,	NULL
GATA-2	NULL
,	NULL
and	NULL
GATA-3	NULL
genes	NULL
were	NULL
performed	NULL
in	NULL
four	NULL
separate	NULL
tubes	NULL
in	NULL
presence	NULL
of	NULL
'/	NULL
of	NULL
cDNA	NULL
,	NULL
the	NULL
couple	NULL
of	NULL
specific	NULL
primers	NULL
,	NULL
and	NULL
*Â°P	NULL
dCTP	NULL
.	NULL

PCR	NULL
control	NULL
was	NULL
obtained	NULL
using	NULL
primers	NULL
specific	NULL
for	NULL
the	NULL
GGPD	NULL
gene	NULL
.	NULL

Aliquots	NULL
of	NULL
the	NULL
PCR	NULL
reaction	NULL
were	NULL
run	NULL
on	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
dried	NULL
and	NULL
autoradiographed	NULL
for	NULL
2	NULL
days	NULL
.	NULL

From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

654	NULL
Interestingly	NULL
,	NULL
a	NULL
proportion	NULL
of	NULL
CD34*	NULL
cells	NULL
expressed	NULL
ta/-1	NULL
gene	NULL
.	NULL

Fractionation	NULL
of	NULL
this	NULL
cell	NULL
population	NULL
allows	NULL
us	NULL
to	NULL
demonstrate	NULL
that	NULL
fa/-1	NULL
is	NULL
not	NULL
expressed	NULL
in	NULL
the	NULL
cell	NULL
fraction	NULL
with	NULL
the	NULL
most	NULL
primitive	NULL
phenotype	NULL
(	NULL
CD34Â°*/CD38~	NULL
)	NULL
but	NULL
is	NULL
present	NULL
in	NULL
the	NULL
cell	NULL
fraction	NULL
with	NULL
the	NULL
phenotype	NULL
of	NULL
committed	NULL
progenitors	NULL
Our	NULL
in	NULL
situ	NULL
hybridization	NULL
studies	NULL
have	NULL
detected	NULL
GATA-1	NULL
and	NULL
tal-	NULL
mRNAs	NULL
in	NULL
the	NULL
same	NULL
hematopoietic	NULL
lineages	NULL
.	NULL

GATA-1	NULL
is	NULL
known	NULL
as	NULL
a	NULL
transcription	NULL
factor	NULL
specific	NULL
for	NULL
the	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mast	NULL
cell	NULL
lineages	NULL
.	NULL

``	NULL
*	NULL
``	NULL
*	NULL
``	NULL
``	NULL
Furthermore	NULL
,	NULL
we	NULL
report	NULL
that	NULL
GATA-1	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
same	NULL
fraction	NULL
of	NULL
CD34*	NULL
than	NULL
tal-1	NULL
,	NULL
which	NULL
mainly	NULL
correspond	NULL
to	NULL
commited	NULL
progenitors	NULL
and	NULL
not	NULL
to	NULL
primitive	NULL
hematopoietic	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
GATA-2	NULL
and	NULL
GATA-3	NULL
have	NULL
clearly	NULL
distinct	NULL
patterns	NULL
of	NULL
expression	NULL
and	NULL
were	NULL
both	NULL
detected	NULL
in	NULL
the	NULL
most	NULL
primitive	NULL
cells	NULL
.	NULL

Altogether	NULL
our	NULL
data	NULL
indicate	NULL
that	NULL
ta/-1	NULL
and	NULL
GATA-1	NULL
are	NULL
coexpressed	NULL
during	NULL
differentiation	NULL
of	NULL
the	NULL
erythroid	NULL
,	NULL
basophilic	NULL
,	NULL
and	NULL
megakaryocytic	NULL
lineages	NULL
from	NULL
the	NULL
committed	NULL
progenitors	NULL
to	NULL
the	NULL
mature	NULL
cells	NULL
.	NULL

These	NULL
results	NULL
are	NULL
in	NULL
accordance	NULL
with	NULL
recent	NULL
datas	NULL
on	NULL
multiple	NULL
leukemic	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
Finally	NULL
,	NULL
several	NULL
findings	NULL
suggest	NULL
indirectly	NULL
that	NULL
GATA-1	NULL
modulates	NULL
the	NULL
expression	NULL
of	NULL
fa/-1	NULL
during	NULL
normal	NULL
hematopoietic	NULL
differentiation	NULL
.	NULL

First	NULL
,	NULL
GATA	NULL
sequences	NULL
are	NULL
present	NULL
in	NULL
the	NULL
1A	NULL
promoter	NULL
of	NULL
both	NULL
human	NULL
and	NULL
mouse	NULL
(	NULL
a/-1	NULL
genes*	NULL
``	NULL
*	NULL
(	NULL
Lecointe	NULL
et	NULL
al	NULL
,	NULL
submitted	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
in	NULL
the	NULL
lineages	NULL
where	NULL
fa/-1	NULL
is	NULL
highly	NULL
expressed	NULL
(	NULL
ie	NULL
,	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mast/	NULL
basophilic	NULL
)	NULL
,	NULL
1	NULL
A	NULL
is	NULL
the	NULL
predominantly	NULL
active	NULL
promoter	NULL
,	NULL
whereas	NULL
the	NULL
1B	NULL
promoter	NULL
appears	NULL
not	NULL
be	NULL
used	NULL
in	NULL
granulocytes	NULL
and	NULL
megakaryocytes	NULL
(	NULL
this	NULL
article	NULL
)	NULL
.	NULL

Third	NULL
,	NULL
GATA-1	NULL
product	NULL
is	NULL
able	NULL
to	NULL
transactivate	NULL
specific	NULL
genes	NULL
of	NULL
these	NULL
lineages	NULL
.	NULL

``	NULL
``	NULL
>	NULL
*	NULL
>	NULL
*	NULL
Fourth	NULL
,	NULL
tal-1	NULL
and	NULL
GATA-1	NULL
are	NULL
expressed	NULL
in	NULL
the	NULL
same	NULL
hematopoietic	NULL
cells	NULL
and	NULL
are	NULL
simultaneously	NULL
downmodulated	NULL
during	NULL
late	NULL
differentiation	NULL
.	NULL

Therefore	NULL
,	NULL
one	NULL
can	NULL
speculate	NULL
that	NULL
GATA-1	NULL
permits	NULL
tal-	NULL
to	NULL
be	NULL
transcribed	NULL
in	NULL
the	NULL
erythroid	NULL
,	NULL
megakaryocytic	NULL
,	NULL
and	NULL
mast/basophilic	NULL
lineages	NULL
.	NULL

However	NULL
,	NULL
GATA-2	NULL
and	NULL
GATA-3	NULL
are	NULL
also	NULL
co-expressed	NULL
with	NULL
ta/-1	NULL
in	NULL
several	NULL
cellular	NULL
types	NULL
;	NULL
ie	NULL
,	NULL
mast	NULL
cells	NULL
and	NULL
developing	NULL
brain	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

``	NULL
``	NULL
*	NULL
This	NULL
implicates	NULL
that	NULL
GATA-binding	NULL
proteins	NULL
,	NULL
different	NULL
from	NULL
GATA-1	NULL
,	NULL
could	NULL
also	NULL
regulate	NULL
the	NULL
transcription	NULL
of	NULL
fa/-1	NULL
.	NULL

Further	NULL
experiments	NULL
are	NULL
required	NULL
to	NULL
directly	NULL
demonstrate	NULL
which	NULL
GATA-binding	NULL
protein	NULL
(	NULL
s	NULL
)	NULL
transactivate	NULL
(	NULL
s	NULL
)	NULL
the	NULL
fa/-1	NULL
gene	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
R.	NULL
Berger	NULL
and	NULL
C.	NULL
Larsen	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
L.	NULL
Coulombel	NULL
,	NULL
F.	NULL
Wendling	NULL
,	NULL
N.	NULL
Debili	NULL
,	NULL
and	NULL
N.	NULL
Methia	NULL
for	NULL
helpful	NULL
suggestions	NULL
during	NULL
the	NULL
course	NULL
of	NULL
this	NULL
study	NULL
and	NULL
for	NULL
purifing	NULL
cells	NULL
,	NULL
to	NULL
J.P.	NULL
Fernand	NULL
and	NULL
C.	NULL
Leforestier	NULL
for	NULL
giving	NULL
leukophoresis	NULL
samples	NULL
,	NULL
and	NULL
to	NULL
D.	NULL
Mason	NULL
,	NULL
M.	NULL
Greaves	NULL
,	NULL
and	NULL
C.	NULL
Civin	NULL
for	NULL
providing	NULL
antibodies	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
M.	NULL
MauchauffÃ©	NULL
and	NULL
V.	NULL
Dellavalle	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
,	NULL
A.	NULL
Katz	NULL
for	NULL
cell	NULL
sorting	NULL
,	NULL
and	NULL
B.	NULL
Boursin	NULL
and	NULL
J.M	NULL
.	NULL

MassÃ©	NULL
for	NULL
preparing	NULL
photographs	NULL
.	NULL

We	NULL
gratefully	NULL
acknowledge	NULL
K.	NULL
Leverett	NULL
and	NULL
N.	NULL
Blumenfeld	NULL
for	NULL
editing	NULL
the	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Begley	NULL
CG	NULL
,	NULL
Aplan	NULL
PD	NULL
,	NULL
Davey	NULL
MP	NULL
,	NULL
Nakahara	NULL
K	NULL
,	NULL
Tchor	NULL
K	NULL
,	NULL
Kurtzberg	NULL
J	NULL
,	NULL
Hershfield	NULL
M	NULL
,	NULL
Haynes	NULL
BF	NULL
,	NULL
Cohen	NULL
DI	NULL
,	NULL
Waldman	NULL
TA	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
Chromosomal	NULL
translocation	NULL
in	NULL
a	NULL
human	NULL
leukemic	NULL
stem-cell	NULL
line	NULL
disrupts	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
d-chain	NULL
diversity	NULL
region	NULL
and	NULL
results	NULL
in	NULL
a	NULL
previously	NULL
unreported	NULL
fusion	NULL
transcript	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:2031	NULL
,	NULL
1989	NULL
MOUTHON	NULL
ET	NULL
AL	NULL
2	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Guglielmi	NULL
P	NULL
,	NULL
Jonveaux	NULL
P	NULL
,	NULL
Cherif	NULL
D	NULL
,	NULL
Gisselbrecht	NULL
S	NULL
,	NULL
MauchauffÃ©	NULL
M	NULL
,	NULL
Larsen	NULL
CJ	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Two	NULL
distinct	NULL
mechanisms	NULL
for	NULL
the	NULL
SCL	NULL
gene	NULL
activation	NULL
in	NULL
the	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
of	NULL
T-cell	NULL
leukemia	NULL
.	NULL

Genes	NULL
Chromosomes	NULL
Cancer	NULL
1:194	NULL
,	NULL
1990	NULL
3	NULL
.	NULL

Chen	NULL
Q	NULL
,	NULL
Cheng	NULL
JT	NULL
,	NULL
Tsai	NULL
LH	NULL
,	NULL
Schneider	NULL
N	NULL
,	NULL
Buchanan	NULL
G	NULL
,	NULL
Carroll	NULL
A	NULL
,	NULL
Crist	NULL
W	NULL
,	NULL
Ozanne	NULL
B	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
The	NULL
1a/	NULL
gene	NULL
undergoes	NULL
chromosome	NULL
translocation	NULL
in	NULL
T	NULL
cell	NULL
leukemia	NULL
and	NULL
potentially	NULL
encodes	NULL
a	NULL
helix-loop-helix	NULL
protein	NULL
.	NULL

EMBO	NULL
J	NULL
9:415	NULL
,	NULL
1990	NULL
4	NULL
.	NULL

Finger	NULL
LR	NULL
,	NULL
Kagan	NULL
J	NULL
,	NULL
Christofer	NULL
G	NULL
,	NULL
Kurtzberg	NULL
J	NULL
,	NULL
Hershfield	NULL
MS	NULL
,	NULL
Nowell	NULL
PC	NULL
,	NULL
Croce	NULL
CM	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
TCL5	NULL
gene	NULL
on	NULL
human	NULL
chromosome	NULL
1	NULL
in	NULL
T-cell	NULL
leukemia	NULL
and	NULL
melanoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sei	NULL
USA	NULL
86:5039	NULL
,	NULL
1989	NULL
5	NULL
.	NULL

Carroll	NULL
AJ	NULL
,	NULL
Crist	NULL
WM	NULL
,	NULL
Link	NULL
MP	NULL
,	NULL
Amylon	NULL
MD	NULL
,	NULL
Pullen	NULL
DJ	NULL
,	NULL
Ragab	NULL
AH	NULL
,	NULL
Buchanan	NULL
GR	NULL
,	NULL
Wimmer	NULL
RS	NULL
,	NULL
Vietti	NULL
TJ	NULL
:	NULL
The	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q32	NULL
;	NULL
q11	NULL
)	NULL
is	NULL
non	NULL
random	NULL
and	NULL
restricted	NULL
to	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
:	NULL
A	NULL
pediatric	NULL
oncology	NULL
group	NULL
study	NULL
.	NULL

Blood	NULL
76:1220	NULL
,	NULL
1990	NULL
6	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Lombardi	NULL
DP	NULL
,	NULL
Ginsberg	NULL
AM	NULL
,	NULL
Cossman	NULL
J	NULL
,	NULL
Bertness	NULL
VL	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
Disruption	NULL
of	NULL
the	NULL
human	NULL
SCL	NULL
locus	NULL
by	NULL
``	NULL
illegitimate	NULL
``	NULL
V-	NULL
(	NULL
D	NULL
)	NULL
-J	NULL
recombinase	NULL
activity	NULL
.	NULL

Science	NULL
250:1426	NULL
,	NULL
1990	NULL
7	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Lombardi	NULL
DP	NULL
,	NULL
Reaman	NULL
GH	NULL
,	NULL
Sather	NULL
HN	NULL
,	NULL
Hammond	NULL
GD	NULL
,	NULL
Kirsh	NULL
IR	NULL
:	NULL
Involvement	NULL
of	NULL
the	NULL
putative	NULL
hematopoietic	NULL
transcription	NULL
factor	NULL
SCL	NULL
in	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Blood	NULL
79	NULL
:	NULL
1327	NULL
,	NULL
1992	NULL
8	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Lecointe	NULL
N	NULL
,	NULL
Jonveaux	NULL
P	NULL
,	NULL
Souyri	NULL
M	NULL
,	NULL
MauchauffÃ©	NULL
M	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Larsen	NULL
CJ	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
Two	NULL
site-specific	NULL
deletions	NULL
and	NULL
t	NULL
(	NULL
1	NULL
;	NULL
14	NULL
)	NULL
translocation	NULL
restricted	NULL
to	NULL
human	NULL
T-cell	NULL
acute	NULL
leukemia	NULL
disrupt	NULL
the	NULL
5	NULL
part	NULL
of	NULL
the	NULL
tal-1	NULL
gene	NULL
.	NULL

Oncogene	NULL
6:1477	NULL
,	NULL
1991	NULL
9	NULL
.	NULL

Brown	NULL
L	NULL
,	NULL
Cheng	NULL
JT	NULL
,	NULL
Chen	NULL
Q	NULL
,	NULL
Siciliano	NULL
MJ	NULL
,	NULL
Crist	NULL
W	NULL
,	NULL
Buchanan	NULL
G	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Site	NULL
specific	NULL
recombination	NULL
of	NULL
the	NULL
ta/-1	NULL
gene	NULL
is	NULL
a	NULL
common	NULL
occurrence	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
.	NULL

EMBO	NULL
J	NULL
9:3343	NULL
,	NULL
1990	NULL
10	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Lombardi	NULL
DP	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
Structural	NULL
characterization	NULL
of	NULL
SIL	NULL
,	NULL
a	NULL
gene	NULL
frequently	NULL
disrupted	NULL
in	NULL
T-cell	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:5642	NULL
,	NULL
1991	NULL
11	NULL
.	NULL

Fitzgerald	NULL
TJ	NULL
,	NULL
Neale	NULL
GAM	NULL
,	NULL
Raimondi	NULL
SC	NULL
,	NULL
Goorha	NULL
RM	NULL
:	NULL
c-tal	NULL
,	NULL
a	NULL
helix-loop-helix	NULL
protein	NULL
,	NULL
is	NULL
juxtaposed	NULL
to	NULL
the	NULL
T-cell	NULL
receptor-8	NULL
chain	NULL
gene	NULL
by	NULL
a	NULL
reciprocal	NULL
chromosomal	NULL
translocation	NULL
:	NULL
t	NULL
(	NULL
1	NULL
;	NULL
7	NULL
)	NULL
(	NULL
p32	NULL
;	NULL
q35	NULL
)	NULL
.	NULL

Blood	NULL
78:2686	NULL
,	NULL
1991	NULL
12	NULL
.	NULL

Bernard	NULL
O	NULL
,	NULL
Azoguy	NULL
O	NULL
,	NULL
Lecointe	NULL
N	NULL
,	NULL
Mugneret	NULL
F	NULL
,	NULL
Berger	NULL
R	NULL
,	NULL
Larsen	NULL
CJ	NULL
,	NULL
Mathieu-Mahul	NULL
D	NULL
:	NULL
A	NULL
third	NULL
promoteur	NULL
is	NULL
specifically	NULL
used	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemias	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
176:919	NULL
,	NULL
1992	NULL
13	NULL
.	NULL

Chen	NULL
Q	NULL
,	NULL
Yang	NULL
CVC	NULL
,	NULL
Tsan	NULL
JT	NULL
,	NULL
Xia	NULL
Y	NULL
,	NULL
Ragab	NULL
AH	NULL
,	NULL
Peiper	NULL
SC	NULL
,	NULL
Carroll	NULL
A	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Coding	NULL
sequences	NULL
of	NULL
the	NULL
ta/-1	NULL
gene	NULL
are	NULL
disrupted	NULL
by	NULL
chromosome	NULL
translocation	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
172:1403	NULL
,	NULL
1990	NULL
14	NULL
.	NULL

Aplan	NULL
PD	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Bertness	NULL
VL	NULL
,	NULL
Nussmeier	NULL
M	NULL
,	NULL
Ezquerra	NULL
A	NULL
,	NULL
Coligan	NULL
J	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
The	NULL
SCL	NULL
gene	NULL
is	NULL
formed	NULL
from	NULL
a	NULL
transcrip-tionally	NULL
complex	NULL
locus	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:6426	NULL
,	NULL
1990	NULL
15	NULL
.	NULL

Begley	NULL
CG	NULL
,	NULL
Aplan	NULL
PD	NULL
,	NULL
Denning	NULL
SM	NULL
,	NULL
Haynes	NULL
BF	NULL
,	NULL
Waldmann	NULL
TA	NULL
,	NULL
Kirsch	NULL
IR	NULL
:	NULL
The	NULL
gene	NULL
SCL	NULL
is	NULL
expressed	NULL
during	NULL
early	NULL
hematopoiesis	NULL
and	NULL
encodes	NULL
a	NULL
differentiation-related	NULL
DNA-binding	NULL
motif	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
86:10128	NULL
,	NULL
1989	NULL
16	NULL
.	NULL

Murre	NULL
C	NULL
,	NULL
Caw	NULL
M	NULL
,	NULL
Schonleber	NULL
P	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
A	NULL
new	NULL
DNA	NULL
binding	NULL
and	NULL
dimerization	NULL
motif	NULL
in	NULL
immunoglobulin	NULL
enhancer	NULL
binding	NULL
,	NULL
daughterless	NULL
,	NULL
MyoD	NULL
and	NULL
mye	NULL
proteins	NULL
.	NULL

Cell	NULL
56:777	NULL
,	NULL
1989	NULL
17	NULL
.	NULL

Jones	NULL
N	NULL
:	NULL
Transcriptional	NULL
regulation	NULL
by	NULL
dimerization	NULL
:	NULL
Two	NULL
sides	NULL
to	NULL
an	NULL
incestuous	NULL
relationship	NULL
.	NULL

Cell	NULL
61:9	NULL
,	NULL
1990	NULL
18	NULL
.	NULL

Murre	NULL
C	NULL
,	NULL
Caw	NULL
M	NULL
,	NULL
Schonleber	NULL
P	NULL
,	NULL
Vaessin	NULL
H	NULL
,	NULL
Caudy	NULL
M	NULL
,	NULL
Jan	NULL
LY	NULL
,	NULL
Jan	NULL
YN	NULL
,	NULL
Cabrera	NULL
CV	NULL
,	NULL
Buskin	NULL
JN	NULL
,	NULL
Hauschka	NULL
SD	NULL
,	NULL
Lassar	NULL
AB	NULL
,	NULL
Weintraub	NULL
H	NULL
,	NULL
Baltimore	NULL
D	NULL
:	NULL
Interactions	NULL
between	NULL
heterologous	NULL
helix-loop-helix	NULL
proteins	NULL
generate	NULL
complexes	NULL
that	NULL
bind	NULL
specifically	NULL
to	NULL
a	NULL
common	NULL
DNA	NULL
sequence	NULL
.	NULL

Cell	NULL
58:537	NULL
,	NULL
1989	NULL
19	NULL
.	NULL

Hsu	NULL
HL	NULL
,	NULL
Cheng	NULL
JT	NULL
,	NULL
Chen	NULL
Q	NULL
,	NULL
Baer	NULL
R	NULL
:	NULL
Enhancer-binding	NULL
activity	NULL
of	NULL
the	NULL
tal-1	NULL
oncoprotein	NULL
in	NULL
association	NULL
with	NULL
the	NULL
E47/E12	NULL
helix-loop-helix	NULL
proteins	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:3037	NULL
,	NULL
1991	NULL
From	NULL
www	NULL
.	NULL

bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

tal-1	NULL
AND	NULL
GATA	NULL
GENE	NULL
EXPRESSION	NULL
IN	NULL
HEMATOPOIESIS	NULL
20	NULL
.	NULL

Green	NULL
AR	NULL
,	NULL
Salvaris	NULL
E	NULL
,	NULL
Begley	NULL
GC	NULL
:	NULL
Erythroid	NULL
expression	NULL
of	NULL
the	NULL
helix-loop-helix	NULL
SCL	NULL
gene	NULL
.	NULL

Oncogene	NULL
6:475	NULL
,	NULL
1991	NULL
21	NULL
.	NULL

Green	NULL
AR	NULL
,	NULL
Lints	NULL
T	NULL
,	NULL
Visvader	NULL
J	NULL
,	NULL
Harvey	NULL
R	NULL
,	NULL
Begley	NULL
CG	NULL
:	NULL
SCL	NULL
is	NULL
coexpressed	NULL
with	NULL
GATA-1	NULL
in	NULL
hematopoietic	NULL
cells	NULL
but	NULL
is	NULL
also	NULL
expressed	NULL
in	NULL
developing	NULL
brain	NULL
.	NULL

Oncogene	NULL
7:653	NULL
,	NULL
1992	NULL
22	NULL
.	NULL

Visvader	NULL
J	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Adams	NULL
J	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
the	NULL
LYL	NULL
,	NULL
SCL	NULL
and	NULL
E2A	NULL
helix-loop-helix	NULL
genes	NULL
within	NULL
the	NULL
hematopoietic	NULL
system	NULL
.	NULL

Oncogene	NULL
6:187	NULL
,	NULL
1991	NULL
23	NULL
.	NULL

Green	NULL
AR	NULL
,	NULL
DeLuca	NULL
E	NULL
,	NULL
Begley	NULL
GC	NULL
:	NULL
Antisense	NULL
SCL	NULL
suppresses	NULL
self-renewal	NULL
and	NULL
enhances	NULL
spontaneous	NULL
erythroid	NULL
differentiation	NULL
of	NULL
the	NULL
human	NULL
leukaemic	NULL
cell	NULL
line	NULL
K562	NULL
.	NULL

EMBO	NULL
J	NULL
10:4153	NULL
,	NULL
1991	NULL
24	NULL
.	NULL

Martin	NULL
DIK	NULL
,	NULL
Zon	NULL
LI	NULL
,	NULL
Mutter	NULL
G	NULL
,	NULL
Orkin	NULL
S	NULL
:	NULL
Expression	NULL
of	NULL
an	NULL
erythroid	NULL
transcription	NULL
factor	NULL
in	NULL
megakaryocytic	NULL
and	NULL
mast	NULL
cell	NULL
lineages	NULL
.	NULL

Nature	NULL
344:444	NULL
,	NULL
1990	NULL
25	NULL
.	NULL

Romeo	NULL
PH	NULL
,	NULL
Prandini	NULL
MH	NULL
,	NULL
Joulin	NULL
V	NULL
,	NULL
Mignotte	NULL
V	NULL
,	NULL
Prenant	NULL
M	NULL
,	NULL
Vainchenker	NULL
W	NULL
,	NULL
Marguerie	NULL
G	NULL
,	NULL
Uzan	NULL
G	NULL
:	NULL
Megakaryocytic	NULL
and	NULL
eryth-rocytic	NULL
lineages	NULL
share	NULL
specific	NULL
transcription	NULL
factors	NULL
.	NULL

Nature	NULL
344:447	NULL
,	NULL
1990	NULL
26	NULL
.	NULL

Yamamoto	NULL
M	NULL
,	NULL
Ko	NULL
LJ	NULL
,	NULL
Leonard	NULL
MW	NULL
,	NULL
Beug	NULL
H	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Engel	NULL
JD	NULL
:	NULL
Activity	NULL
and	NULL
tissue-specific	NULL
expression	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-E1	NULL
multigene	NULL
family	NULL
.	NULL

Genes	NULL
Dev	NULL
4:1650	NULL
,	NULL
1990	NULL
27	NULL
.	NULL

Sawada	NULL
K	NULL
,	NULL
Dai	NULL
CH	NULL
,	NULL
Koury	NULL
ST	NULL
,	NULL
Horn	NULL
ST	NULL
,	NULL
Glick	NULL
AD	NULL
,	NULL
Civin	NULL
CI	NULL
:	NULL
Purification	NULL
of	NULL
human	NULL
blood	NULL
burst-forming	NULL
units-Erythroid	NULL
and	NULL
demonstration	NULL
of	NULL
the	NULL
evolution	NULL
of	NULL
erythropoietin	NULL
receptors	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
142:219	NULL
,	NULL
1990	NULL
28	NULL
.	NULL

Terstappen	NULL
L	NULL
,	NULL
Huang	NULL
S	NULL
,	NULL
Safford	NULL
M	NULL
,	NULL
Lansdorp	NULL
P	NULL
,	NULL
Loken	NULL
M	NULL
:	NULL
Sequential	NULL
generations	NULL
of	NULL
hematopoietic	NULL
colonies	NULL
derived	NULL
from	NULL
single	NULL
nonlineage-commited	NULL
CD34*CD38~	NULL
progenitors	NULL
cells	NULL
.	NULL

Blood	NULL
77:1	NULL
,	NULL
1991	NULL
29	NULL
.	NULL

Mitjavila	NULL
MT	NULL
,	NULL
Nakazawa	NULL
M	NULL
,	NULL
Brignaschi	NULL
P	NULL
,	NULL
Debili	NULL
N	NULL
,	NULL
Breton-Gorius	NULL
J	NULL
,	NULL
Vainchenker	NULL
W	NULL
:	NULL
Effects	NULL
of	NULL
five	NULL
recombinant	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
on	NULL
enriched	NULL
human	NULL
erythroid	NULL
progenitors	NULL
in	NULL
serum-replaced	NULL
cultures	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
138:617	NULL
,	NULL
1989	NULL
30	NULL
.	NULL

Debili	NULL
N	NULL
,	NULL
Hegyi	NULL
E	NULL
,	NULL
Navarro	NULL
S	NULL
,	NULL
Katz	NULL
A	NULL
,	NULL
Mouthon	NULL
MA	NULL
,	NULL
Breton-Gorius	NULL
J	NULL
,	NULL
Vainchenker	NULL
W	NULL
:	NULL
In	NULL
vitro	NULL
effects	NULL
of	NULL
hematopoietic	NULL
growth	NULL
factors	NULL
on	NULL
the	NULL
proliferation	NULL
,	NULL
endoreplication	NULL
and	NULL
maturation	NULL
of	NULL
human	NULL
megakaryocytes	NULL
.	NULL

Blood	NULL
77:2326	NULL
,	NULL
1991	NULL
31	NULL
.	NULL

Titeux	NULL
M	NULL
,	NULL
Berton	NULL
B	NULL
,	NULL
Katz	NULL
A	NULL
,	NULL
Bettaieb	NULL
A	NULL
,	NULL
Fromont	NULL
P	NULL
,	NULL
Bierling	NULL
P	NULL
,	NULL
Vainchenker	NULL
W	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
platelet	NULL
antigens	NULL
identified	NULL
by	NULL
workshop	NULL
antibodies	NULL
and	NULL
their	NULL
reactivity	NULL
with	NULL
myeloid	NULL
cell	NULL
lines	NULL
,	NULL
in	NULL
Knapp	NULL
W	NULL
,	NULL
Dorken	NULL
B	NULL
,	NULL
Gilks	NULL
WR	NULL
,	NULL
Rieber	NULL
EP	NULL
,	NULL
Schmidt	NULL
RE	NULL
,	NULL
von	NULL
655	NULL
derm	NULL
Borne	NULL
AEGK	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Leukocyte	NULL
Typing	NULL
IV	NULL
,	NULL
White	NULL
Cell	NULL
Differentiation	NULL
Antigens	NULL
.	NULL

Oxford	NULL
,	NULL
NY	NULL
,	NULL
Oxford	NULL
University	NULL
,	NULL
1989	NULL
,	NULL
p	NULL
974	NULL
32	NULL
.	NULL

Navarro	NULL
S	NULL
,	NULL
Debili	NULL
N	NULL
,	NULL
Le	NULL
Couedic	NULL
JP	NULL
,	NULL
Klein	NULL
B	NULL
,	NULL
Breton-Gorius	NULL
J	NULL
,	NULL
Doly	NULL
J	NULL
,	NULL
Vainchenker	NULL
W	NULL
:	NULL
Interleukin-6	NULL
and	NULL
its	NULL
receptor	NULL
are	NULL
expressed	NULL
by	NULL
human	NULL
megakaryocytes	NULL
:	NULL
In	NULL
vitro	NULL
effects	NULL
on	NULL
proliferation	NULL
and	NULL
en-doreplication	NULL
.	NULL

Blood	NULL
77:461	NULL
,	NULL
1991	NULL
33	NULL
.	NULL

Mouthon	NULL
MA	NULL
,	NULL
Navarro	NULL
S	NULL
,	NULL
Katz	NULL
A	NULL
,	NULL
Breton-Gorius	NULL
J	NULL
,	NULL
Vainchenker	NULL
W	NULL
:	NULL
c-jun	NULL
and	NULL
c-fos	NULL
are	NULL
expressed	NULL
by	NULL
human	NULL
megakaryocytes	NULL
.	NULL

Exp	NULL
Hematol	NULL
20:909	NULL
,	NULL
1992	NULL
34	NULL
.	NULL

Chomezynski	NULL
P	NULL
,	NULL
Sacchi	NULL
N	NULL
:	NULL
Single	NULL
step	NULL
method	NULL
of	NULL
RNA	NULL
acid	NULL
guanidium	NULL
-	NULL
thiocyanate-phenol-chloroforme	NULL
-	NULL
extraction	NULL
.	NULL

-	NULL
Anal	NULL
Biochem	NULL
162:156	NULL
,	NULL
1987	NULL
35	NULL
.	NULL

Gough	NULL
NM	NULL
:	NULL
Rapid	NULL
and	NULL
quantitative	NULL
preparation	NULL
of	NULL
cytoplasmic	NULL
RNA	NULL
from	NULL
small	NULL
numbers	NULL
of	NULL
cells	NULL
.	NULL

Anal	NULL
Biochem	NULL
173:93	NULL
,	NULL
1988	NULL
36	NULL
.	NULL

Saiki	NULL
RK	NULL
,	NULL
Gelfand	NULL
DH	NULL
,	NULL
Stoffel	NULL
S	NULL
,	NULL
Scharf	NULL
SJ	NULL
,	NULL
Higuchi	NULL
R	NULL
,	NULL
Horn	NULL
GT	NULL
,	NULL
Mullis	NULL
KB	NULL
,	NULL
Erlich	NULL
HA	NULL
:	NULL
Primer	NULL
directed	NULL
enzymatic	NULL
amplification	NULL
of	NULL
DNA	NULL
with	NULL
a	NULL
thermostable	NULL
DNA	NULL
polymerase	NULL
.	NULL

Science	NULL
239:488	NULL
,	NULL
1988	NULL
37	NULL
.	NULL

Boehm	NULL
T	NULL
,	NULL
Spillantini	NULL
MG	NULL
,	NULL
Sofroniew	NULL
MV	NULL
,	NULL
Surani	NULL
MA	NULL
,	NULL
Rab-bitts	NULL
TH	NULL
:	NULL
Developmentally	NULL
regulated	NULL
and	NULL
tissue	NULL
specific	NULL
expression	NULL
of	NULL
mRNAs	NULL
encoding	NULL
the	NULL
two	NULL
alternative	NULL
forms	NULL
of	NULL
the	NULL
LIM	NULL
domain	NULL
oncogene	NULL
rhombotin	NULL
:	NULL
Evidence	NULL
for	NULL
thymus	NULL
expression	NULL
.	NULL

Oncogene	NULL
6	NULL
:	NULL
695	NULL
,	NULL
1991	NULL
38	NULL
.	NULL

Evans	NULL
T	NULL
,	NULL
Felsenfeld	NULL
G	NULL
:	NULL
The	NULL
erythroid-specific	NULL
transcription	NULL
factor	NULL
Eryf-1	NULL
:	NULL
A	NULL
new	NULL
finger	NULL
protein	NULL
.	NULL

Cell	NULL
58:877	NULL
,	NULL
1989	NULL
39	NULL
.	NULL

Dorfman	NULL
DM	NULL
,	NULL
Wilson	NULL
DB	NULL
,	NULL
Bruns	NULL
GA	NULL
,	NULL
Orkin	NULL
SH	NULL
:	NULL
Human	NULL
transcription	NULL
factor	NULL
GATA-2	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
267:1279	NULL
,	NULL
1992	NULL
40	NULL
.	NULL

Ho	NULL
IC	NULL
,	NULL
Vorhees	NULL
P	NULL
,	NULL
Martin	NULL
N	NULL
,	NULL
Karpinski	NULL
Oakley	NULL
B	NULL
,	NULL
Tsai	NULL
SF	NULL
,	NULL
Orkin	NULL
SH	NULL
,	NULL
Leiden	NULL
JM	NULL
:	NULL
Human	NULL
GATA-3	NULL
:	NULL
A	NULL
lineage-restricted	NULL
transcription	NULL
factor	NULL
that	NULL
regulates	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a	NULL
gene	NULL
.	NULL

EMBO	NULL
J	NULL
10:1187	NULL
,	NULL
1991	NULL
41	NULL
.	NULL

Joulin	NULL
V	NULL
,	NULL
Bories	NULL
D	NULL
,	NULL
Elouet	NULL
JF	NULL
,	NULL
Labastie	NULL
MC	NULL
,	NULL
ChrÃ©tien	NULL
S	NULL
,	NULL
MattÃ©i	NULL
MG	NULL
,	NULL
Romeo	NULL
PH	NULL
:	NULL
A	NULL
T-cell	NULL
specific	NULL
TCR	NULL
Ã©	NULL
binding	NULL
protein	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
human	NULL
GATA	NULL
family	NULL
.	NULL

EMBO	NULL
J	NULL
10:1809	NULL
,	NULL
1991	NULL
42	NULL
,	NULL
Evans	NULL
T	NULL
,	NULL
Felsenfeld	NULL
G	NULL
:	NULL
Trans-activation	NULL
of	NULL
a	NULL
globin	NULL
promoter	NULL
in	NULL
nonerythroid	NULL
cells	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
11:843	NULL
,	NULL
1991	NULL
43	NULL
.	NULL

Martin	NULL
DIK	NULL
,	NULL
Orkin	NULL
S	NULL
:	NULL
;	NULL
Transcriptional	NULL
activation	NULL
and	NULL
DNA	NULL
binding	NULL
by	NULL
the	NULL
erythroid	NULL
factor	NULL
GFI/NFE1/Eryf	NULL
1	NULL
.	NULL

Genes	NULL
Dev	NULL
4	NULL
:	NULL
1886	NULL
,	NULL
1990	NULL
44	NULL
.	NULL

Orkin	NULL
S	NULL
:	NULL
GATA-binding	NULL
transcription	NULL
factors	NULL
in	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
80:575	NULL
,	NULL
1992	NULL
From	NULL
www	NULL
.	NULL

by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

blood	NULL
===	NULL
Expression	NULL
of	NULL
tal-1	NULL
and	NULL
GATA-binding	NULL
proteins	NULL
during	NULL
human	NULL
hematopoiesis	NULL
ETY	NULL
Op	NULL
~	NULL
2	NULL
A	NULL
gs	NULL
%	NULL
,	NULL
'	NULL
.	NULL

:	NULL
e	NULL
@	NULL
.	NULL

2	NULL
(	NULL
f	NULL
MA	NULL
Mouthon	NULL
,	NULL
O0	NULL
Bernard	NULL
,	NULL
MT	NULL
Mitjavila	NULL
,	NULL
PH	NULL
Romeo	NULL
,	NULL
W	NULL
Vainchenker	NULL
and	NULL
D	NULL
Mathieu-Mahul	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/81/3/647.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

